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ABSTRACT

MOLECULAR INTERACTIONS BETWEEN THE WilLMS' TUMOR
TRANSCRIPTION FACTOR AND THE ARYL HYDROCARBON RECEPTOR
DURING NEPHROGENESIS AND ITS IMPACT ON FETAL PROGRAMMING
OF RENAL DISEASE

Adrian Nanez
December 3, 2007

Embryonic development requires the orchestration of temporally precise
genetic events that culminate in the formation of a complete organism. The
molecular mechanisms responsible for ontogenesis are regulated by
environmental and somatic factors in utero that activate or repress the
expression of numerous genetic elements resulting in fetal programming of adult
diseases. The aryl hydrocarbon receptor (AHR) is an important nuclear
transcription factor both during embryogenesis and throughout maturity in
multiple organisms. Building upon interesting studies establishing a direct, novel
link between AHR anel post-transcriptional regulation of the \Nilms' tumor
suppressor (WT1) gene, the overall goal of the project was to elucidate the role
of AHR in the regulation of WT1 during nephrogenesis. The evidence shows that

v

in utero exposure to environmentally relevant exposures of benzo(a)pyrene
(BaP), a polycyclic aromatic hydrocarbon (PAH) and AHR Iligand, results in AHR
allele-specific deficits in renal development manifested as decreased numbers of
glomeruli, induction in urinary albumin, and podlocytopenia. These findings were
consistent with metanephric and organ culture data where PAHs caused AHR
allele-specific reduction in renal cell differentiation markers, dysregulation of WT1
mRNA splice variants, and decreases

111

direct 'NT1 transcriptional targets.

Observed deficits were linked to disruption of constitutive AHR signaling, as
siRNA-mediated AHR degradation reproduced similar effects. Collectively, this
evidence defined a novel role for the AHR in renal development and in fetal
programming of PAH-induced environmental disease.
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CHAPTER 1
INTRODUCTION

Embryonic development requires the orchestration of temporally precise
genetic and genetic events that culminate in the formation of a complete
organism. The molecular mechanisms responsible for ontogenesis are regulated
by environmental and somatic factors in utero that activate or repress the
expression of numerous genetic elements. The aryl hydrocarbon receptor (AHR)
is an important nuclear transcription factor both during embryogenesis and
throughout maturity in multiple organisms. The discovery of potent,
environmental chemicals that act as AHR ligands has revealed that dysregulation
of AHR function during embryonic development can have deleterious effects. Of
relevance to this project, from a medical perspective, are epidemiological reports
that maternal exposure to environmental tobacco smoke, a complex mixture of
chemicals containing high concentrations of ligands of the AHR such as
polycyclic aromatic hydrocarbons (PAH), mediates developmental abnormalities
(Sasaki et al., 2006). Also of note is that children of parents who work in
occupations associated with increased exposure to AHR ligands have a higher
incidence of Wilms' tumors (Olshan et al., 1990). The discovery of novel
functions of AHR during development, coupled to molecular interactions of AHR

with developmental transcription factors highlight a potential mechanism for
compromised development following disruption of AHR signaling. This
dissertation focuses on the interactions between AHR and WT1 in the regulation
of nephrogenesis.

Renal development proceeds in three morphologically distinguishable
stages: the pronephros, mesonephros., and metanephros. During
embryogenesis, the kidney derives from Hle nephric ridge in the intermediate
mesoderm. At gestational day 8 in mice and day 22 in humans, the pronephric
duct gives rise to the pronephros which elongates to form the Wolffian duct.

A

morphologically distinct mesonephros appears in mice at gestational day 9.5 and
day 24 in humans. During mesonephric development, glomeruli are linked to the
Wolffian duct forming immature nephrons. Shortly thereafter, the mesonephric
ducts and remnants of the tubular structure are incorporated into development of
the male genital system and disappear altogether in females (Sakurai and
Nigam, 2000).

The metanephros (also referred to as the permanent kidney) develops at
gestational day 11 in mice and day 28 in humans. During metanephric
development, the Wolffian duct develops into the ureteric bud which then enters
the nephrogenic mesenchyme and stimulates condensation of mesenchymal
cells around the invading ureteric bud. The reciprocal interactions between the
invading ureteric bud and the metanephric mesenchyme initiate mesenchymal-

epithelial cell transformation (MET) wherein epithelial cells are stimuilated to
differentiate into the precluding structures for glomerular development (Kuure et
al.,2000). Both proximal and distal tubules are derived from mesenchymal cells

receiving differentiation signalls from the invading ureteric bud. Reciprocal
signals stemming from the induced mesenchyme stimulate branchin~J
tubulogenesis of the ureteric bud culminating in development of the collecting
duct system.

Of importance to our work are the mechanisms that ~Jovern the
mesenchymal-to-epithelial transformation and the resulting influence on
metanephric development and renal function. Growth of the ureteric bud from
the Wolffian duct is regulated by the Wilms' tumor (WT1), Pax2, Lim1, Sall1, and
Eya1 transcription factors in cooperation with the ancillary proteins formin, Gdnf,
Ret, and Gfra1 (for review see (Kuure et aI., 20(0). Homozygous deletion of only
one regulator is sufficient to inhibit ureteric bud outgrowth causing bilateral renal
agenesis or severe forms of renal dysgenesis (Kreidberg et al., 1993a; Maas et
al., 1994; Pichel et aI., 1996; Sanchez et al., 1996; Schuchardt et aI., 1994;

Shawlot and Behringer, 1995a; Torres et al., 1995; Treanor et aI., 1996; Xu et aI,
1999). Pax2-null mice do not develop the caudal portion of the Wolffian duct and
do not develop the ureteric bud (Torres et aI, 1995). In WT1-null mice, ureteric
bud growth is stunted

resultin~l

in renal aplasia (Kreidberg et al., 1993a). Sall1

deficiency does not alter ureteric bud growth, but inhibits invasion of the
metanephric mesenchyme resulting in bilateral renal aplasia (Nishinakamura et

..,
j

aI., 2001). Gdnf produced in the metanephric mesenchyme functions with Ret to

promote ureteric bud outgrowth. Disruption of either Gdnf or Ret alters renal
branching morphogenesis dUE~ to improper uretleric bud outlJrowth (Cacalano et
aI., 1998; Schuchardt et aI., 1!994).

A cascade of genetic events initiated by transcriptional control from master
switches including WT1, Lim1, and Pax2 transcription factors regulate MET
(Figure 1) (Kuure et al., 2000) . WT1 is a known regulator of Pax2 which in turn
binds to the 5' promoter of Gdnf to induce transcription (Brophy et aI., 2001).
Lim1-null mice develop a mesonephros, but are devoid of adult kidneys due to
deficits in Pax2 transcriptional control (Tsang et al., 2000). 'While the importance
of master switch transcriptional regulators is well-established, the mechanisms
controlling their function and the downstream consequences are poorly
understood.

Other influences in ureteric bud morphogenesis are cellular interactions
involving extracellular matrices (ECM) from both the ureteric bud and the
metanephric mesenchyme. ECM protein expression is tightly regulated via
growth factor signaling pathways which, in turn, are regulated by master switch
transcription factors. Laminins compose the majority or the mature basement
membrane (Engel, 1993), and have been shown to participate in branching
morphogenesis and tubulogenesis. Exposure to anti-laminin5 blocking antibody
inhibits renal development of cultured metanephroi by preventing association

4

Figure 1. Representation ()f ureteriic bud and metanephric mesenchyme
interactions in nephron development. Renal cell differentiation requires the
sequential activation of gene expresslion from several key regulators and
downstream effectors. These include secreted factors (\/\lnt, FGF, BMP, and
GDNF), receptors (c-ret), oncogenes, transcription factors (WT1, Pax2, Lim1),
enzymes (HS2-sulfotransferase), signal transducers (RARa), proteolytic
enzymes, extracellular matrix (integrin a8), endothelium attractant (VEGF), and
glomerular regulators (PDGF, and nephrin) (Kuure et aI., :WOO).
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with a3~1 and a6~4-integrin receptors (Zent et al., 2001). Laminin 1, consisting of
a-, ~-, and v-subunits, is a critical component of epithelial cell polarization chiefly
expressed in comma and S-shaped bodies (Durbeej et aI., '1996; Ekblom, 1993).
In cultured metanephroi, mesenchymal cell excreted nidogen interacts with the
laminin1 Y1-subunit to facilitate epithelial cell polarization through a mechanism
dependent upon dystoglycan and a6~1""integrin (Ekblom et 081., 1994). Exposure
to antibodies generated against a1, or

()1~1Y1-subunits

cultured metanephroi either through binding of the
complex or the

()6~1-integrin

inhibits development of

dystro~Jlycan

membrane

receptor (Sonnenberg et 081., 1990).

Cells stemming from the ureteric bud must digest ECM proteins to
facilitate invasion. Both matrix metalloproteases (MMPs) and serine proteases
are known to facilitate renal development. Membrane-type matrix 1 (MT-1-MMP)
and MMP-2 oligonucleotide antisense inhibits metanephric development
dependent on the TIMP-2 inhibitor activity (Kanwar et 081., 1999; Ota et 081 .. 1998).
While t-PA and u-PA serine proteases are expressed in developing metanephroi,
and have been shown to participate in tubulogenesis in organ culture, mouse
models deficient in expression of either protein have a normal renal phenotype
(Carmeliet et al., 1994). Thus, renal morphogenesis requires the function of
master switch transcription factors which directly or indirectly regulate
intra/extracellular signaling that facilitate renal cell differentiation, branching
morphogenesis, and ultimately

nephro~Jenesis.

7

The Wilms' tumor suppressor transcription factor (VVT1), in concert with a
variety of transcriptional co-regulators, guides renal development through both
direct and indirect modulation of target genes necessary for renal cell
differentiation including syndecan1 (Synd1), Pax2, E-cadherin (E-cad), insulin-like
growth factor /I (lgf2r), epidermal growth factor receptor (E!~fr) and retinoic acid
receptor-a (Rara) (Hosono et aI., 2000; Hosono et aI., 19199; Ryan et aI., 1995).
The WT1 gene encodes a Cis r His 2 zinc fingered protein that can regulate
biological events via transcriptional activation of target genes or by association
with factors participating in RNA processing. The WT1 gene was first
characterized as one of the

gE~netic

causes of the pediatric nephroblastoma,

Wilms' tumor, which is histolo!Jically characterized by cellular populations of
epithelial, stromal, and undifferentiated phenotype (Bennin!Jton and Beckwith,
1975). Whille WT1 is only inactivated in 15% of Wilms' tumors, dysregulation of
WT1 function results in clinical manifestation of developmental deficiencies
affecting genitourinary development such as WAGR (Wilms' tumor, aniridia,
genitourinary defects and mental retardation), Beckwith-\/viedemann, DenysDrash, and Frasier syndrome (for review see(Lee and

HabE~r.

2001 )).

Of importance to our work is the ability of WT1 to function as a "master
switch" regulating mesenchymal-epithelial differentiation in renal development
(Avner, 1993). In both humans and mice, WT1 protein is expressed in the
condensing mesenchyme, renal vesicle, and glomerular epithelium of developing
kidney (Buckler et al., 1991; Pritchard-Jones et al., 1990). In adulthood, visceral
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epithelial cells (podocytes) of the kidnE!y and Sertoli cells of the seminiferous
tubules in the testis are the only populations that express \/\/T1. Homozygous
WT1-/- mice do not develop normally, die in utero, and do not differentiate into
metanephric kidney from the existing pronephros

(Kreidber~l

et al. ,1993b).

WT1 activity is regulated in cis by different ratios of its own splice variants
or in trans by proteins such as bone marrow zinc finger 2 (BMZF2), Pax2, and
Par4 (Hohenstein and Hastie, 2006; Lee et aI., 2002). Wr'l protein expression
varies from 36 possible isoforrns resulting from alternative splicing, start codons,
and RNA editing (Filgure 2) (Hohenstein and Hastie, 2006). Perhaps the most
studied regulatory mechanism involves the formation of \/\/T'l ±KTS splice
variants. KTS splice variants are formed at a site in exon 9 via the insertion of a
Iysine-threonine-serine (KTS) between the third and

fourt~l

zinc finger. The

resulting change tarlgets -KTS WT1 protein expression for the nucleus and
modifies DNA binding specificity leading to activation and/or repression of
different genetic elements (Menke et aI., 1998b; Niksic et al., 2004). WT1 protein
from the +KTS mRNA transcript localizes to the nucleus and is thou!~ht to
participate in RNA processing via interactions with known splicing factors such as
U2AF65 (Davies et aI., 1998; Ladomery et aI., 2003; Larsson et aI., 1995). In
mouse models, deletion of either the -KTS or the +KTS is lethal soon after birth
due to distinct renal deficits (Hammes et aI., 2001). In humans, reduced
WT1 +KTS mRNA isoform results in severE~ kidney and gonad developmental
deficits, collE~ctively known as Frasier syndrome (Barbaux et al., 1997). Similarly,
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Figure 2. Schematic representation of the WT1 gene. Accounting for
alternative transcriptional start sites and rnRNA splicing, the WT1 locus encodes
for at least a theoretical maximum of 36 isoforms. Alternative start codons,
exons, splice sites, and RNA editing are depicted in red. Functional domains of
known biological importance are depicted in green (Hohenstein and Hastie,
2006).
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mouse models with homozygous deletion of the -KTS WT1 variant results in
small kidneys, reduced glomeruli number, a decrease in nephrogenic area, as
well as streak gonads (Hammes et al., 2001). +KTS-null mice achieve a higher
degree of renal maturation, compared to --KTS -/- mice, characterized by
immature glomeruli and undifferentiated podocyte cell populations resulting in
renal nephropathy

E~videnced

by hematuria (Hammes et al., 2001). This

demonstrates that the integrity of WT1 function as regulated by mRNA splice
variant ratio is critical to renal development.

Addition of 1"7 amino acids comprising the entirety of exon 5 (±17aa)
occurs in a region chiefly thought to

re!~ulate

transactivation with regulatory

partners and nuclear translocation (Robelis, 2005; Wang et a/., 1995). Insertion
or deletion of 17aa does not alter renal development morphologically, and to date
the impact of these isoforms on WT1 function remains uncertain.
Overexpression of +17aa has been reported in human Wilms' tumor (Simms et

al., 1995). In cell culture models, +17aa overexpression alters cellular
morphology and induces proliferation (Hewitt and Saunders, 1996). In lymphoma
cell lines +17aa

oVE~rexpression

inhibits apoptosis by repressing expression the

pro-apoptotic protein Bak (Ito et a/., 2006). Our work shows that induction of
+17aa WT1 protein correlates with loss of renal cell differentiation markers Igf1 r,
Wnt4 and E-cad (Falahatpisheh and Ramos, 2007).

12

Yet another regulatory domain occurs at the N-terminal residues 1-182
which encode a dimerization region implicated in the regulatory mechanism
exerted by dominant negative mutants (Englert et a/., 1995; Reddy et aI., 1995).
To date, the mechanisms regulating WT1 function are poorly understood. The
majority of evidence supports the theory that WT1 is regulated by relative
abundance of mRNA isoforms resulting in proteins that function to either repress
or promote transcription of genetic targets necessary for renal cell differentiation.
The relative contribution that +KTS plays in RNA processing has yet to be
determined . The molecular mechanisms

re!~ulating

WT1 transcription, splicing,

and overall function remain uncertain. Work in our laboratory suggests that
integrity of AHR signaling functions directly and/or indirectly in regulation of WT1
mRNA ratios.

The aryl hydrocarbon receptor was the first characterized member of the basic
helix loop helix- Per Arnt Sim (bHLH-PAS) family of transcription factors (Figure
3). The PAS domain is characterized by a region of homology between the
founding members Per (the protein product of the Orosophila Period gene)
(Reddy et al., 1986), ARNT (the AHR nuclear translocator) (Hoffman et aI.,
1991), and Sim (the product of the Orosophila-Single minded locus) (Nambu et
al., 1991). Eukaryotic PAS domains serve as recognition sites for interactions

with other PAS proteins, cellular chaperones, or in the case of the AHR, a
regulatory ligand binding site. The bHLH domain also participates in recognition
of other bHLH and facilitates recognition of the major groove of tar~let genetic

13

Figure 3. Members of the PAS family. Domain structures for the founding
members PER, ARNT, and SIM are shown as well as others including AHR, HIF1, TRH, and SIMILAR The basic region is depicted in blue, basic helix-Ioophelix in grey, PAS domain in red, and transactivation domain in yellow.
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elements (Murre et a/., 1994). While bHLH-PAS proteins share similar structure
and function, the AHR is the only member known to be re!~ulated by ligand
activation (Figure 4).

The AHR was initially characterized due to its participation in the induction
of xenobiotic metabolizing enzymes (XMEs) necessary for removal of exo!~enous
compounds. Early work showed that response to xenobiotics such as polycyclic
aromatic hydrocarbons (PAHs), known inducers of XMEs, varied between strains
of mice that were highly responsive (C57BLl6,J) and nonresponsive (DBA/2) with
respect to induction of XME machinery. Genetic manipulation creating congenic
strains expressing different AHR alleles identified a single autosomal locus
coined AH locus (Goujon et a/., 1972; Nebert et a/., 1972). However, it was not
until the development of high-affinity radioligands, AHR-specific anti:bodies, and
purified receptor fractions that AHR-ligand interactions were deduced.

A. combination of various techniques has led to our current understanding
of AHR biology in which ligand binding results in AHR disassociation from two
molecules of the chaperone heat shock protein 90 (HSP90), binds the Xassociated protein 2 (XAP2) and p32 (Figure 5). The resulting complex exposes
a nuclear localization sequence that facilitates nuclear translocation. This
complex, in turn, binds to the aryl hydrocarbon receptor nuclear translocator
(ARNT) resulting in DNA binding to sequences containing 5'-GCGGGGGCG-3'
and (TCC)n repeats (Denison and Nagy, 2003). Translocation of thE~ AHR·ligand

16

Figure 4. Molecular structure of the AHR. The nuclear localization (NLS),
bHLH, PAS, and transactivation (TAD) domains are labeled. Areas
characterized for dimerization, ligand binding, and repressor bindinn are labeled
and depicted with lines. Cys 216 has been highlighted as a key residue for DNA
binding and Ala 374 for high affinity ligand binding.
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Figure S. The molecular mechanism of AHR-regulated gene expression as
mediatE~d

by ligand activation. Ligand binding results in AHR disassociation

from two molecules of the chaperone heat shock protein 90 (HSP90), binds the
X-associated protein 2 (XAP2) and p32. The resulting complex exposes a
nuclear localization sequence that facilitates nuclear translocation. This complex
in turn binds to the aryl hydrocarbon receptor nuclear translocator (ARNT)
resultin~1

in DNA binding to AHR response element (AHRRE) sequences

containing 5'-GCGGGGGCG-3' and (TCC)n repeats. Translocation of the Ahrligand complex triggers proteolytic degradation.
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complex to the nucleus can also trigger proteolytic degradation regardless of
ARNT binding (Roberts and Whitelaw, 1999). AHR is also regulated by negative
feedback inhibition in which the nuclear AHR complex activates transcription of
the AHR repressor protein (AHRR) responsible for binding the xenobiotic
response element (XRE) (Mimura et aI., 1999).

The induction of XMEs resulting from AHR-ligand binding is the most
widely studied function of AHR. AHR interacts with xenobiotic response
elements (XREs) in the regulatory regions of genes such as cytochrome P450 1A
(CYP1A 1), CYP1A2, CYP1 B1, glutathione-S-transferase Ya (GSTYa) and
UGT1A6 NAD(P)H-quinone oxidoreductase which, in turn, function to metabolize
PAHs into compounds modified for excretion via glutathione conjugation. An
example relevant to our work involves the biotransformation of benzo(a)pyrene
(BaP), a common environmental pollutant that among other effects acts as an
AHR ligand (Figure 6). Upon exposure to BaP, P450

exprE~ssion

is induced to

catalyze the epoxidation of the parent hydrocarbon into BaP 7,8 epoxide and
then into BaP 7,8 diol-9, 10 epoxide (Parkinson, 2001). While these metabolic
steps are necessary for clearance of the hydrocarbon, they also activate BaP into
compounds that exert deleterious effects ranging from DNA mutagenesis,
oxidative stress, protein modifications, and disruption of molecular signaling
pathways (for review see (Miller and Ramos, 2001 a).

21

Figure 6. Metabolic activation of BaP. BaP is metabolized into BaP 7,8
epoxide by cytochrome P450's. Hydrolysis mediated by epoxide hydrolase (EH)
creates BaP 7,8 diol which is further metabolized by cytochrome P450's into the
BaP 7,8 diol-9, 10 epoxide.
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AHR ligands are categorized as either synthetic in nature (resulting from a
nonbiological process such as combustion or de novo synthesis) (Figure 7) or as
naturally occurring (synthesized as part of a biological process) (Figure 8).
Further classification into exogenous and or endogenous is difficult due to dietary
ligands that are technically exogenous in nature, but that are transformed into
ligands by natural biological processes. The high affinity ligands such as 2,3,7,8tetrachlorodibenzo-p-dioxin (TCOO), BaP and 3-methylcolanthrene (3MC) are
synthetic in nature. Synthetic ligands bind AHR with high affinities in the pM to
nM range whereas naturally occurring ligands such as the tryptophan metabolites
bind with lower affinities in the nM to iJM range.

Historically, studies have focused on the ubiquitous high affinity ligands
and the resulting regulation of AHR biology, however evolutionary comparison
has shown that the AHR gene is conserved across both vertebrate and
invertebrate species of which many are not exposed to classical aromatic ligands
(Hahn, 2002; Hahn et al., 2006). This poses the question: Are there true
endogenous ligands that regulate AHR activity?

The first report of a candidate endogenous AHR ligand came from studies
in which Hepa1c1c7 cells were exposed to hemin, bilirubin and biliverdin.
Bilirubin induced CYP1A 1 mRNA and 7-ethoxyresorufin-O-deethylase (EROO)
activity in a dose-dependent manner (Sinal and Bend, 1997). In agreement with

24

Figure 7. Structures of selected classical AHR ligands that are considered
synthetic in nature. All are known inducers of AHR-dependent gene expression
(Denison and Nagy, 2003).
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Figure 8. Structures of AHR ligands categorized as naturally occurring. All
are derivatives arising from metabolism of tryptophan by mammalian enzymes
(Denison and Nagy, 2003).
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studies identifying tryptophan metabolites as AHR ligand, aspartate
aminotransferase expressed in mouse heart tissue activated AHR signaling by
converting L-tryptophan into indole-3-pyruvate (Bittinger et aI., 2003). The
compound 2-(1'H-indole-3'-carbonyl)-thiaxole-4-carboxylic acid methyl ester (ITE)
was isolated from mouse tissue and found to act as a potent AHR agonist in cell
extracts, cultured cells, and in vivo animal models as evidenced by AHR binding,
CYP1A 1 protein induction and xenobiotic response element (XRE) reporter
activity (Henry et al., 2006). While investigating the role of AHR in shear stress
and vascular physiology, low density lipoprotein (LDL) was found to increase
AHR signaling due largely to lipoprotein modification (McMillan and Bradfield,
2007a). The relative contribution of either of these ligands to AHR function in
vivo remains to be elucidated. However, it is likely that AHR signaling in vivo is
regulated by endogenous ligands.

Genetic polymorph isms in murine strains aided the discovery and
1

characterization of the AHR gene. In mice, four distinct AHR alleles, AHb- , AH
2,

b

-

AHb-3 , and Af-f have been characterized (Poland etal., 1994). C57BLl6J mice

express AHb- 1 which encodes for the amino acid alanine at codon 375 resulting in
a 10-fold higher ligand binding affinity (Kd=6-1 OpM) compared to DBA/2 mice
(Kd=37pM) that express the Af-f allele containing valine at codon 375 (Okey et
d

aI., 1989). Accordingly, the congenic strain D2NAhr was developed and

contains the exact genetic background as the C57BLl6J strain except for
expression of the AHRd allele. While polymorphisms in mouse AHR typically

29

occur in the ligand binding domain, human polymorph isms manifest in the
transactivation domain at codons 517,554, and 570 (Harper et al., 2002). As in
mice, human populations express AHR variants that can vary 10-fold in TCDD
binding affinity. However, the mechanisms for this occurrence do not involve the
517, 554, and 570 codon polymorphic variants (Harper et aI., 2002; Nebert et aI.,
2004). The combination of 517 and 554 polymorphisms results in AHR protein
that binds TCDD and DNA, but does not sustain CYP1A1 induction (Wong et al.,
2001a; Wong et al., 2001b). It is thought that expression of the lower affinity
AHR, similar to the protein product from the murine AHRd allele, protects the
majority of the human population from the toxic effects of PAHs (Harper et aJ.,
2002). With the abundance of environmental agents able to activate AHR, it is
crucial to determine the exact nature of human AHR allelic variation and the
resulting consequences on AHR function.

The bulk of AHR studies have focused on modulation and/or participation
in the response to and clearance of xenobiotic compounds. Evidence continues
to mount implicating AHR in proliferation, development, adhesion and migration,
and proteasomal degradation of steroid hormone receptors (for reviews see
(8arouki et al., 2007; Ohtake et al., 2007)). Studies using AHR -/- mice support a
scenario in which the AHR acts as an important nuclear transcription factor
during embryogenesis and throughout maturity in multiple organisms. AHR-/mice exhibit deficits in vascular structures stemming from a failure of the ductus
venosus to close and result in reduced liver weight, microvesicular fatty
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metamorphosis, prolonged extramedullary hematopoeisis, and portal
hypercellularity (Fernandez-Salguero et aI., 1995; Lahvis et aI., 2000; Lahvis et
al., 2005; Schmidt et aI., 1996). Our lab has shown that AHR-null mice exhibit

delayed nephrogenesis resulting in compromised renal development as
evidenced by nephropenia and decreases in renal vasculature (Falahatpisheh
and Ramos, 2003; McMillan and Bradfield, 2007b). We have also shown that
these changes can be reproduced by downregulation of AHR protein upon ligand
binding.

Of direct relevance to studies of renal function are experiments in which
AHR -/- mice were found to have cardiac hypertrophy and elevated mean arterial
pressure (Lund et aI., 2003; Lund et al., 2006). Hypertension correlated to
increased in endothelin-1 and angiotensin II, k.nown regulators of cardiomyocyte
hypertrophy (Gavras and Gavras, 2002; Yamazaki et aI., 1996). Angiotensin \I is
a potent renal vasoconstrictor that constricts efferent arterioles and increases
blood pressure. Thus, it is possible that hypertension in AHR -/- mice is caused
by compromised renal development; although this hypothesis remains to be
tested.

More studies are required to determine how environmental PAH

exposure affects AHR protein expression and function in the context of
organogenesis.

As noted previously, PAHs are compounds formed during the incomplete
burning of organic substances such as gas, oil, wood, tobacco, and charbroiled
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meat. The primary source of exposure occurs through inhalation of compounds
via tobacco smoke, wood smoke, ambient air, and dietary intake. PAHs like BaP
are hlighly lipophilic chemicals that move across cell membranes with relative
ease. Upon entry into the cells they associate with hydrophobic molecules and
are dispersed throughout the cell accumulating in the mitochondria and nucleus
(Barhoumi et al., 2000; Zhu et al., 1995). Once in the bloodstream they bind
albumin and lipoproteins and are rapidly distributed throughout the body (for
review see (Miller and Ramos, 2001 b)). Average PAH exposure can range from
3 to 15 jJg/day depending on dietary intake. Humans exposed to active or
passive smoke can receive as much as 30 jJg/day (Menzie et al., 1992a; Menzie
etal., 1992b; Santodonato etal., 1981).

In mouse models of inhalation exposure, BaP bioaccumulates primarily in
the kidney and to a lesser extent in the liver (Mitchell, 1982). Consistent with the
known expression of XMEs, elimination in the liver occurs at 12 hours postexposure while Significant amounts of BaP are still present in the kidneys for up
to 48 hours (Mitchell, 1982). In utero exposure with radiolabeled BaP show that
BaP enters the fetus and activates classical responses triggered by PAH
metabolism including increases in CYP450 and BaP hydroxylase expression
(Neubert and Tapken, 1988a; Neubert and Tapken, 1988b).

PAH exposure is known to be a causative factor in carcinogenesis,
atherogenesis, and embryotoxicity (for review see (Miller and Ramos, 2001 b)).
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In mice, metabolism of BaP into compounds that give rise to DNA adduct
formation results in tumor formation in both skin and systemic models.
Intraperitoneal injections of the 7,8-diol-9, 10-epoxide (BPDE) metabolite induces
systemic malignant lymphoma as a result of DNA mutagenesis (Kapitulnik et aI.,
1977). PAHs affect growth and differentiation of aortic smooth muscle cells and
may participate in atherogenesis (Holderman et al., 2000; Kerzee and Ramos,
2000; Ramos and Parrish, 1995). The mechanistic causalities of PAH-induced
diseases are complicated by the variety of effects they exert such as DNA
mutagenesis, oxidative stress, protein oxidation, and modifications of signal
transduction pathways.

PAH exposure during critical windows of fetal development exhibit
teratogenic and embryotoxic effects (Lummus and Henningsen, 1995;
MacKenzie and Angevine, 1981a; Rodriquez et al., 1999; Wells et al., 1997;
Winn and Wells, 1997). Murine in utero exposure of 150 mg/kg BaP causes T
cell deficiencies in offspring (Lummus and Henningsen, 1995). In utero exposure
to as little as 10 IJg/kg results in reproductive deficits in both male and female
offspring manifest by a reduction in the size of seminiferous tubules and corpus
lutea deficiencies, respectively (Mackenzie and Angevine, 1981 b).

Of relevance to our work is the extensive evidence linking maternal PAH
exposure to fetal deficits. Fetal tobacco syndrome is characterized by maternal
exposure to PAHs in the form of tobacco smoke and results in reductions in birth
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weight, height, thoracic circumference (for review see (Nieburg et al., 1985)).
Evidence supports the theory that active smoking morphologically alters the
placenta compromising fetal capillary function resulting in a reduction of oxygen
flow to the developing fetus (Bush et al., 2000a; Bush et al., 2000b). Sasaki et

al. has provided the first in vivo human evidence that AHR, CYP1A 1, and GST1
genetic polymorph isms influence

fe~tal

health upon maternal tobacco smoke

exposure. Expression of AHR protein with arg/arg at codon 211 significantly
lowered birth weight and length. Interestingly, variants of enzymes regulated by
AHR activity (CYP1A1 m1/m2 + m2/m2) or involved in PAH elimination (GSTM1/-) sensitized fetuses to the effects of maternal smoking (Sasaki et a/., 2006).
This study directly links PAH exposure to deficits in AHR signaling in the context
of fetal programming.

Fetal programming is a process whereby a stimulus at a sensitive critical
period of development induces lasting effects on the structure or function of the
organism (Barker, 2004). Some of the strongest evidence of fetal programming
involves the correlation betwe~~n low birth weight (LBW) and compromised renal
development. Chronic kidney disease (CKO) affects greater than 20 million
people in the U.S .. It is thought that the two major causes are hypertension
(HTN) and diabetes mellitus. The kidney is a key regulator of HTN. Most genetic
mutations associated with HTI'J involve proteins expressed in the kidney and
regulated renal function such as epithelial Na+ channel (Lifton et al., 2001). This
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led Brenner et al. to postulate tlhat HTN may be associated with congenital
deficits in nephron number

resultin~l

in impaired renal function.

In humans, a direct com31ation exists between birth weight and nephron
number. LBW humans have been shown to have reduced nephron numbers and
glomerular hypertrophy. An increase in 1kg of birth weight results in the addition
of 250,000 nephrons (Hoy et al., 2003; Hughson et al., 2003). LBW adults with
low nephron number are prone to nnicroalbuminuria, proteinuria, and decreased
glomerular filtration (Celsi et al., 1998; Nwagwu et al., 2000; Sanders et al.,
2005). Thus, it is likely that intrauterine factors, including PAHs, compromise
renal development resulting in low nephron number. The reduced renal capacity
may result in glomerular hypertension and subsequent compensatory
hypertrophy that in turn leads to disruption of the glomerular basement
membrane manifest as glomerulosclerosis. Continued glomerular injury may
lead to increases in nephron loss further reducing renal capacity as evidenced by
decreases in Na+ excretion and glomerular filtration rates. As depicted in Figure
9, this culminates in HTN exacerbating glomerulosclerosis, nephron loss, and
proceeds until progressive renal failure.

The work completed as part of this dissertation builds upon interesting
studies completed in the Ramos laboratory for the past 10 years establishing a
direct link between AHR and cieficits in renal cell differentiation (Alejandro et al.,
2000) and post-transcriptional regulation of WT1 isoform expression
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Figure 9. Proposed mechanism IOf fetall programming in hypertension,
renal disease, and glomerulalr filtration. Intrauterine factors, including PAHs,

compromise renal development resulting in low nephron number (Celsi et a/.,
1998; Nwagwu et al., 2000; Sanders et al., 2005). Reduced renal capacity
results in glomerular hypertension and subsequent compensatory hypertrophy
that in turn leads to disruption of thl3 glomerular basement membrane manifested
as glomerulosclerosis. Continued

!~Iomerular

injury leads to increases in

nephron loss further reducing renal capacity as evidenced by decreases in Na+
excretion and glomerular filtration rates. This culminates in HTN exacerbating
glomerulosclerosis, nephron loss, and proceeds until progressive renal failure
(Zandi-Nejad et a/., 2006).
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(Falahatpisheh and Ramos, 2003). Using a metanephric kidney organ culture
system, we have shown that exposure to BaP, a hydrocarbon ligand for the AHR,
inhibits nephrogenesis and increases -KTS/+KTS WT1 mRNA ratios.
Hydrocarbon challenge of metanephroi extracted from AHR knockout mice are
protected from BaP-induced deficits in nephrogenesis and express higher
amounts of +KTS mRNA, indicating that AHR is required in nephrogenesis.

The overall goal of the research summarized in this dissertation was to
elucidate the role of AHR in the regulation of WT1 function during nephrogenesis.
Specifically, studies were conducted to test the hypothesis that ligand-activated
AHR regulates murine nephrogenesis in vivo by altering expression of renal cell
differentiation genes through modulation of WT1 mRNA splicing. This hypothesis
was tested by three specific aims deSigned to:

1)

Determine whether in utero BaP exposure causes AHR dependent
inhibition of nephrogenesis and alterations in WT1 mRNA splicing;

2)

Elucidate the time-related effects of AHR ligands on nephrogenesis
and WT1 splicing, and;

3)

Evaluate the influence of alterations in WT1 splicing on downstream
WT1 targets and cell differentiation.

In chapter 2, we evaluate the impact of in utero BaP exposure on
nephrogenesis and WT1 mRNA splicing. Previous work has established that
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exposure of metanephric kidney cultures (isolated from C57BLl6J wild type mice)
for 4 days to BaP results in inhibition of nephrogenesis and modulation of WT1
mRNA variants. AHR-null metanephroi exhibit similar deficits in nephrogenesis
in the absence of BaP exposure (Falahatpisheh and Ramos, 2003). While this
regimen was adequate for initial studies, httle was known about the effects of in
utero BaP exposure on nephrogenesis and WT1 mRNA splicing in vivo. Thus,
studies were designed to evaluate the impact of BaP treatment on pregnant
C57BLl6J and D2NAHR mice expressin~1 the responsive and nonresponsive
d

AHR alleles, respectively. Of particular relevance was the fact that our studies
examined concentrations of BaP known to be relevant to human exposures to
the hydrocarbon. We hypothesized that iln utero BaP exposure results in AHR
mediated inhibition of renal development and alterations in WT1 mRNA splicing.

Chapter 3 summarizes the results of studies completed to define the
kinetic profiles of BaP-induced inhibition of nephrogenesis and alteration of WT1
splicing. Experiments focused on definin!J the mechanism for AHR participation
in renal developmental control. Previous work established that exposure of
metanephric kidney cultures to BaP for 4 days results in inhibition of nephrogenic
differentiation and modulation of WT1 isoforms regulated by AHR. While this
work implicated a relationship between AHR and WT1, the kinetic profiles of AHR
activation, changes in WT1 mRNA splicing, and inhibition of nephrogenic
inhibition had not been defined. Thus, experiments were conducted to determine
the extent to which sub-chronic BaP exposure induces nephrogenic inhibition
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and alterations in AHR-WT1 signaling. Through the use of pharmacological AHR
antagonists and D2NAHR d metanephroi we examined the molecular mechanism
by which PAHs affect nephrogenesis. We hypothesized that BaP-induced
disruption of AHR signaling downregulates renal cell differentiation through a
pathway that involves altered conservation of WT1 mRNA splice variant ratios.

Chapter 4 focuses on the influence of alterations in WT1 splicing on
downstream WT1 targets and cell differentiation. The key event in
nephrogenesis is the transdifferentiation of mesenchymal cells to epithelial cells.
Recent work has shown that degradation of AHR via ligand-activated
ubiquitination or siRNA interference induces the +17aa and -KTS splice variants
of the Wt1 gene (Falahatpisheh and Ramos, 2003; Falahatpisheh and Ramos,
2005). Different WT1 isoforms are believed to promote and/or repress different
genetic targets (Hosono et al., 1999; Reddy and Licht, 1996), suggesting that
epithelial conversion is differentially influenced by different WT1 spllice variants.
The concept that different WT1 splice varilants regulate different functions is
consistent with the notion that translation of -KTS mRNA produces a protein
product that localizes to the nucleus, whereas the +KTS protein displays
preferential cytoplasmic localization. Murine kidney cell lines at two different
stages of cellular differentiation were used to determine the role of alterations in
WT1 splicing in the regulation of renal cell differentiation. Subsequent
experiments were conducted to determine if alterations in various VVT1 isoforms
lead to induction/repression of proteins directly regulated by WT1 and involved in
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metanephric development. We hypothesized that overexpression of -KTS or the
+17aa WT1 isoforms compromises differentiation of mK4, but not mK3 cell lines
and selectively modulate downstream tar£lets of WT1.
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CHAPTER 2

DEREGULATION OF FETAL PROGRAMMING IN THE DEVELOPING KIDNEY
BY I3ENZO(A)PYRENE

Summary

Polycyclic aromatic hydrocarbons (PAHs) are environmentally ubiquitous
chemicals identified as potential disruptors of developmental programming and
inducers of transformed phenotypes in several organ systems. Recent studies in
this laboratory have established that exposure of developing kidneys in vitro to
SaP, a prototypical PAH, causes deficits in renal cell differentiation and ablates
nephrogenesis. The present studies were conducted to determine if similar
changes are seen in vivo following in utero exposure to BaP at concentrations
relevant to those likely to be encountered by humans during environmental
exposures. Pregnant C57BLl6J (C57) and B6.02N-Ah,o/J (02N) mice
expressing the wild type AHR allele or an AHR allele with reduced ligand binding
affinity, respectively, were treated by gavage with 0.1 or 0.5 mg/kg BaP daily
beginning 10 days post coitum (dpc) through 13. This exposure regimen was
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designed to mimic human exposure levels during periods of nephrogenesis.
Pregnant mice were allowed to come to term and offspring were examined at 7
days and at 12 months post partum for indicators of renal morphology and
measurements of renal function. Exposure to 0.1 mg/kg and 0.5 mg/kg BaP
caused AHR allele-specific decrE~ases in ~llomerular number and altered renal
morphology compared to vehicle-treated controls. Developmental deficits were
primarily of glomerular origin, as evidenced by decreased podocyte numbers and
increased levels of urinary albumin, a marker of glomerular function. Markers for
collecting duct and distal tubule injury, namely, rat papillary antigen 1 (RPA 1) and
glutathione S-transferase Yb1 (GSTYb1), were unchanged. Both morphological
and molecular endpoints correlated with the loss of the AHR protein in kidneys
from BaP-exposed mice. These results implicate BaP as an influential factor in
fetal programming during the course of murine renal development.

Introduction

Fetal programming is a process whereby a stimulus at a sensitive critical
window of development induces lasting effects on the structure or function of the
organism (Barker, 2004). Correlations between low birth weight (LBW) and renal
development have provided some of the strongest evidence for environmental
disruption of fetal programming. LBW humans have reduced nephron numbers
and glomerular hypertrophy. In humans, an increase of 1kg in birth weight
results in the addition of 250,0010 nephrons (Hoy et aI., 2003; Hughson et al.,
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2003). LBW adults with low nephron number are prone to microalbuminuria,
proteinuria, and decreased glomerular filtration (Celsi et al., 1998; Nwagwu et aJ.,
2000; Sanders et aI.., 2005). Reduced renal capacity results in glomerular
hypertension and subsequent compensatory hypertrophy that in turn leads to
disruption of the glomerular basement membrane manifested as
glomerulosclerosis. Sustained glomerular injury exacerbates nephron loss
further reducing renal glomerular filtration rate. A reduction in renal capacity
further increases blood pressure and completes a futile cycle of
glomerulosclerosis and nephron loss that may ultimately result in progressive
renal failure (Zandi-Nejad et al., 2006). Thus, it is important to examine the
mechanisms by which intrauterine factors disrupt ontogenesis.

PAHs are compounds formed during the incomplete burning of organic
substances such as gas, oil, wood, tobacco, and charbroiled meat. Routes of
exposure include inhalation via tobacco smoke, wood smoke, ambient air, as well
as dietary intake (USDHHS, 1995). PAH exposure is a known causative factor in
carcinogenesis, atherogenesis, and embryotoxicity and these effects are
believed to be mediated by mechanisms involving DNA mutagenesis, oxidative
stress, protein oxidation, and deficits in signal transduction (for review see (Miller
and Ramos, 2001 b)). PAHs acting as ligands of nuclear transcription factors
such as aryl hydrocarbon receptor (AHR) can induce deficits in embryogenesis
via disruption of constitutive AHR signaling (Falahatpisheh and Ramos, 2003;
Nanez and Ramos, 2007; Peters et al., 11999a).
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AHR is a basic helix-loop-helix transcription factor activated by
endogenous and exogenous ligands including PAHs. Upon ligand binding, AHR
disassociates from two molecules of the chaperone heat shock protein 90
(HSP90), binds the X-associated protein 2. (XAP2) and p32. The resulting
complex exposes a nuclear localization sequence that facilitates nuclear
translocation. This complex in turn binds
nuclear translocator (ARNT or

HIF1~)

1[0

the aryl hydrocarbon receptor

in the nucleus resulting in DNA binding to

sequences containing 5'-GCGGGGGCG-3' and (TCC)n repeats (Denison and
Nagy, 2003). Translocation of the AHR-linand complex to the nucleus triggers its
proteolytic degradation regardless of ARNIT binding (Roberts and Whitelaw,
1999). Depending upon cell

tYPE~,

AHR can be regulated through negative

feedback inhibition of AHR transcriptional activation by the AH repressor protein
(AHRR) (Mimura et al., 1999).

In mice, four distinct AHR alleles, AHb- 1 , AHb-2 , AHb-3 , and A~f have been
characterized (Poland et aI., 1994). C57BLl6J mice express A~-1 which
encodes for the amino acid alanilne at codon 375 and results in a 5-fold higher
ligand binding affinity (Kd=6-10pM) compared to DBAl2 mice (Kd=3?pM) which
express the AH~ allele containing valine at codon 375 (Okey et al., 1989). The
ala-val substitution results in a conformational change that substantially
decreases ligand binding affinity without affecting association with HSP90. This
renders the AHRd allele functionally null as exposure to ligand does not promote
nuclear translocation, association with ARNT, AHRRE transcriptional activation,
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or proteasomal degradation when compared to AHRb (Poland and Glover, 1990;
Poland et aI., 1994). Accordingly, the con!~enic strain D2NA.hrd was developed to
contain the exact genetic background as the C57BLl6J strain except for
d

expression of the Af-fR allele (Nebert et ai., 1972). Humans express AHR
genetic polymorphic variants that alter AHIR function. Relevant to our studies is
that expression of AHR protein with af!~/arg at codon 211 sinnificantly lowered
birth weight and length in offspring exposed to in utero tobacco smoke (Sasaki et

a/., 2006). Interestingly, variants of enzymes regulated by AHR activity (CYP1Al
m1/m2 + m2/m2) or involved in PAH elimination (GSTM1 -/-) sensitized fetuses
to the effects of maternal

smokin!~

(Sasaki et al., 2006). This study directly links

PAH exposure to deficits in AHR signaling in the context of fetal pronramming.

Evidence continues to mount implicating AHR in the regulation of
proliferation, development, adhesion and migration, and proteasomal
degradation (for reviews see (Barouki et 61/.,2007; Ohtake et a/., 20(7)). Based
on previous findings in our laboratory, as well as others, we hypothesized that
AHR acts as an important nuclear transcription factor durin~~ embryogenesis and
throughout maturity (Ramos et. aI., 2007). AHR-/- mice exhibit deficits in
vascular structures stemming from a failure of the ductus venosus to close and
result in reduced liver weight, microvesicular fatty metamorphosis, prolonged
extramedullary hematopoeisis, and portal hypercellularity (Fernandez-Salguero
et al., 1995; Lahvis et aI., 2000; Lahvis et al., 2005; Schmidt et al., 1996). Our

laboratory has shown that AHR-l1ull mice exhibit delayed nl=phrogenesis resulting
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in compromised renal development as evidenced by nephropenia and
decreases in renal vasculature (Falahatpisheh and Ramos, 2003; McMillan and
Bradfield, 2007b). These changes can be reproduced by decreased AHR protein
levels upon ligand binding (Nanez and Ramos, 2007). In addition, AHR -/- mice
were found to have endothelin1 and angiotensin II mediated cardiac hypertrophy
and elevated mean arterial pressure, conditions directly linked to impaired renal
functions (Gavras and Gavras, 2002; Lund et a/., 2003; Lund et al., 2006;
Yamazaki et al., 1996).

Using a metanephric kidney or9an culture system, our laboratory has
shown that BaP exposure inhibits nephro!Jenesis as evidenced by decreases in
branching morphogenesis, glomerular number, and decreases in undifferentiated
cells. BaP-induced developmental deficits correlate with downregulation of renal
cell differentiation markers and expression of the AHR. Here., we test the
hypothesis that in utero exposure to BaP inhibits nephrogenesis through a
mechanism involving ligand-mediated disruption of AHR signaling . As an
evolving role for AHR in developmental biology continues to unfold, this work will
help to determine the mechanisms by which disruption of AHR signaling alters
fetal programming within the context of exposure to environmental chemicals.

Methods
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In utero SaP exposure
Time-pregnant C57BLl6J and B.6 D2N-AHRd/j females were exposed to
BaP (Sigma-Aldrich, St. Louis, MO) or medium chain triglyceride oil (MCT) (Mead
Johnson Nutritionals, Evansville, IN) at doses of 0.1 mg/kg and 0.5 mg/kg, 10
through 13 d.p.c. by oral gavage. Murine in utero exposure of 150 mg/kg BaP is
known to cause offspring T cell deficiencies (Lummus and Henningsen, 1995).
Thus, the concentrations chosen for study were considerably lower than those
established for in utero toxicity and terat0genecity (Lummus and Henningsen,
1995; MacKenzie and Angevine, 1981 a; Hodriquez et al., 1999; Wells et aI.,
1997; Winn and Wells, 1997) and

whE~n

normalized for species-dependent

temporal differences in development, are representative of human exposure of at
risk populations (Menzie et aI., 1992a; Menzie et aI., 1992b; Rebagliato et aI.,
1995).

Sources of human and animal PAH exposure include air, water, food, and
soil and average 6·-15 I-lg/day

(MenziE~

et al., 1992a; Menzie et al., '1992b).

Depending on environment, food is thou~Jht to be the largest contributor. Active
or passive smoking doubles PAH exposure to 30 I-lg/day (Santodonato et a/.,
1981). Assuming an average bodyweight of 60 kg, the average human intake is
estimated to be 0.25 I-lg/kg/day to

O.E)

I-lg/kg/day for passive or active tobacco

exposure. Allowing for differences in the length of mouse and human gestation,
0.012 I-lg/kg/day is estimated as the predicted relevant murine exposure. While
the 0.1 and 0.5 I-lgJkg exposure levels examined in our study are higher than
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those encountered by the general U.S. human population, they are functionally
relevant to human polymorphisms affectin!J PAH metabolism and AHR signaling
(Sasaki et aI., 2006; Wong et al., 2001a; Vvong et al., 2001b), and'considerably
lower than PAH levels examined in risk assessment studies of carcinogenicity
and teratogenicity (Lummus and Henningsen, 1995; MacKenzie and Angevine,
1981a; Rodriquez et aI., 1999; Wells et al., 1997; Winn and Wells, 1997).

Seven days after birth, pups were Huthanized and renal tissue was fixed in
situ. The heart, liver, testis, and aorta were extracted to assess system-specific
effects of in utero BaP exposure. Pups from the same litter were monitored for
12 months and examined for markers of nephropathy.

Glomerular morphometric analysis and Immunohistochemistry
Resected kidneys were fixed in fresh 4% paraformaldehyde at 4°C for 12
hr and embedded in paraffin.

5~m

sections were cut and processed, then

stained with hematoxylin and eosin. For 'Immunohistochemical analysis, slides
were treated under pressure with Vector Antigen Unmasking Solution® (Vector
Laboratories, Burlingame, CA). WT1 (180) (Santa Cruz Biotechnology, Santa
Cruz, CA) or AHR rabbit polyclonal (Biomollnternational, Plymouth Meeting, PA)
antibodies were applied overnight at 4°C in a solution of 0.3% Triton X-1 00 and
5% goat serum (Vector Laboratories, Burlingame, CA). Primary antibodies were
bound to a goat anti-rabbit biotinylated secondary antibody (Invitrooen-Molecular
Probes, Carlsbad, CA), amplified with ABCelite®, developed with
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diaminobenzidine (DAB), and counterstained with Mayer's Hematoxylin (Vector
Laboratories, Burlingame, CA).

Glomerular numbers were quantified manually and verified by image
analysis. For all analyses, images of entire kidney cross sections from 5 renal
planes were captured at 20X. Using the Zeiss Axiovision Rei 4.3 .image analysis
software, images of entire renal cross sections were filtered for intensity, color
thresholding, and size of glomerular v\fT1 IHC signal allowing for distinction
between glomeruli and other structures.

Values were normalized to renal area

in all instances.

WT1 and AHR protein was measured by optimizing thresholding relative
to negative control serial sections. Indices of protein expression were expressed
as sum density normalized to total renal area. Podocyte number was quantified
using WT1 signal filtered for intensity, color thresholding, and size. All values
were normalized to glomerular number as measured by image analysis.

Statistical significance was evaluated using SPSS statistical software
(SPSS, SPSS Inc., Chicago, IL) and testing for significance between groups by
analysis of variance (ANOVA) and least sum of square difference (LSD).

Urinary albumin
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Individual urine samples were collected and stored at -BODC in urine
stabilizing buffer (Biotrin International, Dublin, Ireland). Under reducing
conditions, 11..11 of urine sample was loaded on a 4-12% Bis-Tris NuPage gel
(Invitrogen, Carlsbad, CA) and processed for silver staining as per
manufacturer's instructions (Invitrogen, Carlsbad, CA). Sum density values were
calibrated to a mouse serum albumin standard curve ranging from 10 to 0.001
1..1 gl 1..1 I.

Urinary Renal Papillary Antigen 1 (RPAl1) and Glutathione S-transferase
Yb1 (GSTYb1) Measurements
Enzyme immunoassays for the quantitative measurement of RPA 1 and
GSTYb1 were performed as per manufacture's instructions (Biotrin International,
Dublin, Ireland). Briefly, 96 well microtiter plates were supplied conjugated with
anti-RPA1 or GSTYb1 IgG. Urine was diluted 1/25 and equilibrated for 1 hr at
room temperature before addition of antibody-enzyme conjugate. After substrate
development, absorbance was read at 4!;Onm with 630nm as a

refE~rence.

Absorbance was normalized to internal controls and expressed as relative units.

Analysis of WT1 Splice Variants
Total RNA was extracted usin!~ TRlzol® and cDNA was synthesized using
SuperScript II (Invitrogen, Carlsbad CA) as per manufacturer's instructions.
Quantitative PCR using primers specific for WT1 isoforms was performed to
detect differences in the ratio of WT1 splice variants (±KTS) and (±17aa)
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(Falahatpisheh and Ramos, 2003; Falahatpisheh and Ramos, 2007). Primers
were designed using Beacon Designer 5.1 to create amplicons from 150-300
base pairs with an average melting temperature of 58°C.

Western Blot Analysis of WT1 Prote,in Isoforms
Protein was extracted using T PER reagent (Pierce, Rockford, IL) as per
manufacturer's directions. Samples were run on 4-12% Bis-Tris NuPage gels
(Invitrogen, Carlsbad, CA) under reducing conditions and transferred to a PVDF
membrane where bound protein was detected using WT1 (180) rabbit polyclonal
antibody (Santa Cruz Biotechnology, Santa Cruz, CA) and a horseradish
peroxidase-conjugated secondary antibody. Previous work in the laboratory has
shown that differences in ±17aa mRNA splice variants can be resolved at the
protein level via gel electrophoresis.

Results

Fetal SaP exposure alters renal development and function in offspring
C57 and D2N mice had similar numbers of glomeruli at 7 day old (Figure
1A). In utero exposure to both 0.1 and 0.5 mg/kg BaP caused a significant
decrease in glomerular numbers in C:57 but not D2N (Figure 1A and B).
Offspring kidneys of BaP-exposed dams exhibited a reduction in glomerular size
and increases in undifferentiated cells compared to controls (Figure 1B). D2N
mice expressing the low affinity AHR C! allele were protected from BaP-induced
glomerular deficits (Figure 1A and B).
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Figure 1. SaP inhibits nephrogenesis via an AHR allele specific
mechanism. Kidneys were resected from 7-day old C57 and D2N-AHR d mice
exposed to either 0.1, 0.5 mg/kg BaP or MCT oil vehicle in utero. Tissue was
fixed in 4% paraformaldehyde and processed for modified hematoxylin and eosin
staining, to visualize differentiated StruictUI'eS. Serial sections were processed for
immunohistochemical analysis of WT1: protein and counterstained with
hematoxylin. Glomerular number was quantified manually and verified by image
analysis. Images of entire kidney cross sl8ctions from varying renal planes were
captured at 20X. Intensity and color thresholding for glomerular WT1 signal was
modified to exclude both small and large artifacts approximating glomerular
number then normalized to renal area. Accuracy was controlled for by manual
analysis of random images. Statistical

si!~nificance

was calculated by ANOVA

and LSD post hoc tests p < 0.05. Panels A and B, show that exposure to BaP
decreases glomerular number in C57 mice via an AHR allele-specific
mechanism. Scale represents 200 I..lm.
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Albuminuria is a hallmark of renal nephropathy and a common clinical
marker for the diagnosis of renal disease (Cameron and Blandford, 1966). In
agreement with previous work, albumin was the most abundant protein present in
mouse urine (Figure 2B) (Marshall and W'illiams, 1987). C57 and D2N mice
excreted similar amounts of urinary albumin demonstrating that expression of the
AHRd allele does not affect renal development in unstressed animals (Figure 2A).
In utero BaP exposure resulted in dose-dependent increases in albuminuria, at
12 months old, which were dependent upon expression of the responsive AHRb
allele. Under these conditions, D2N mice were unaffected (Figure 2A and 2B).

Fetal SaP exposure is associated with specific glomerular deficits
The podocyte is a key

re~Julator

in glomerular basement membrane (GBM)

homeostasis by lending support to the glomerular tuft and functioning as the chief
filtration barrier (Abrahamson, 1987; Sariola et al., 1984). Podocytes produce
the majority of the molecular structures necessary for GBM maintenance
(Abrahamson, 1987). Murine podocyte division halts 7 days post birth. Thus,
impaired renal development, injury, or de-generation of the podocyte population
results in deficits affecting adult renal function specifically impairing glomerular
filtration (Mundel and Kriz, 1995). Immunohistochemical quantification of
podocyte number revealed no differences between C57 and D2N mice (Figure
2C). Both 0.1 and 0.5 mg/kg in utero BaP exposure elicited decreases in
podocyte numbers (Figure 2C). D2N mice did not display BaP-induced deficits in
podocyte number, further suggE~sting the importance of ligand binding in BaP-
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Figure 2. BaP exposure induc.~s glomE~rular specific injury. Urine was
collected from 12 month old offspring C57 and D2N-AHR d mice exposed to either
0.1, 0.5 mg/kg BaP or MCT oil in utero. Proteins were separated on a 4-12%
Bis-Tris gel and developed by silver stain. Albumin values were normalized to
mouse serum albumin standard curve (10, 1, 0.1, 0.01, and 0.001 fJg/fJl) and
statistical significance was calculated by ANOVA and LSD post hoc tests p <
0.05. Panel A, BaP alters albumin urinary levels in C57 mice via a dosedependent, AHR allele-specific mechanism. Panel B, silver stain visualization of
mouse urinary albumin in C57 miice exposed in utero to 0.5 mg/kg MCT oil or
BaP. Panel C, Immunohistochemical analysis of podocyte number was
quantified using WT1 signal filtered for intensity, color thresholding and size
normalized to glomeruli number. BaP exposure results in AHR allele-specific
decreases in podocyte numbers. Panel D, Immunohistochemical analysis of total
WT1 signal quantified using WT11 normalized to podocyte number. BaP
exposure results in AHR allele-specific decreases in podocyte numbers.
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induced deficits in nephrogenesis (Figure 2C). As expected, both 0 1 and 0.5
mg/kg in utero BaP exposure decreased \NT1 protein expression in an AHR
allele specific manner (Figure 20). WT1 is a known regulator of nephrogenic
outcomes in humans and mice (Niaudet and Gubler, 2006). WT1 activity is
chiefly regulated in cis by expression of specific mRNA ratios resulting from
posttranscriptional modification

(HohenstE~in

and Hastie, 21006; Lee et al., 2002).

Ongoing work will examine the effects of in utero BaP exposure on WT1 mRNA
splice variant expression in C57 and 02N mice.

Classical markers of nephropathy such as blood urea nitrogen, urinary
creatinine, and albuminuria generally manifest in severely compromised kidneys
(Mathieson, 2004). A new class of urinary markers has been developed to detect
subtle renal injury that precludes gross nephropathy. Rat papillary antigen 1
(RPA 1) and glutathione S-transferase Yb1 (GSTYb1) are markers of collecting
duct and distal tubule injury, respectively (Falkenberg et al., 1996; Hildebrand et
al., 1999; Kilty et al., 1998). RPA1 is specifically produced in the papillary

collecting duct and is released into the urine upon exposure to classical renal
toxins (Hildebrand et al., 1999). GSTYb1 is highly expressed in the distal and
convoluted tubules of the murine renal tubules and is released into the urine
upon injury (Eger et al., 1997; Sundberg et al., 1994a; Sundberg et al., 1994b).
The low level in utero SaP exposure did not alter urinary HPA 1 or (JSTYb1 levels
in either C57 or 02N mice (Figure 3). Taken together these findings indicated
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Figure 3. BaP exposure does not induce collecting duct or distal tubular
injury. Urine was collected from 12-month old offspring C57 and D:2N-AHR d
mice exposed to either 0.1, 0.5 mg/kg BaP or MCT oil in utero. Absorbances
from enzyme immunoassay detection of RPA1 and GSTYb1 were normalized to
internal controls expressed as relative units. Statistical significance was
calculated by ANOVA and LSD post hoc tests p < 0.05. Panels A an B, BaP
exposure does not alter relative amounts of RPA 1 or GSTYb1
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that in utero BaP-exposure results in renatl deficits consist!:mt with glomerular
neph ropathy.

In utero BaP exposure decreases AHR protein expression
Consistent with known AHR biology, in utero exposure to BaP resulted in
dose-dependent decreases in AHR protein in C57 (Figures 4A and B). Loss of
receptor protein correlated with AHR variant-specific reductions in glomerular
and podocyte number, as well as increased urinary albumin. These results
suggest that environmentally relevant in utero BaP exposures are sufficient to
activate AHR and in doing so, promote degradation, likely altering constitutive
signaling.

Discussion

Extensive in utero exposure studies have identified PAHs as potent
modulators of fetal development that exert teratogenic and embryotoxic effects,
(Lummus and Henningsen, 1995; MacKenzie and Angevine, 1981 a; Rodriquez et
al., 1999; Wells et aI., 1997; Winn and Wells, 1997). However, the subtle effects

stemming from environmentally relevant Goncentrations of PAHs have yet not
being characterized. The known differences in murine and human renal
development make accurate comparisons of BaP exposure challenging. Our
exposure regimen accounts for the normalization of species differences in renall
developmental duration and approximates likely maternal exposures that are
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Figure 4. AHR expression correlates with deficits in

m~phrogenesis.

Kidneys were resected from 7-day old C57 mice exposed to either 0.1, 0.5 mg/kg
BaP or MCT oil in utero. Tissue was fixed in 4% paraformaldehyde and
processed for modified Hematoxylin and Eosin staining, to visualize differentiated
structures. Serial sections were processed for immunohistochemical analysis of
AHR protein and counter stained with hematoxylin. AHR signal was calculated
by creating a thresholded value for AHR signal accounting for nonspecific signal
from negative control serial sections processed without primary antibody and
primary antibody neutralized with blocking peptide. Sum density was normalized
to area and statistical significance was calculated by ANOVA and LSD post hoc
tests p < 0.05. Panels A and B show that exposure to BaP decreases AHR
protein levels in a dose-dependent manner. Scale represents 200 IJm.
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functionally relevant to human polymorphisms affecting PAH metabolism and
AHR signaling (Sasaki et a/., 2006; Wong et a/., 2001 a; Wong et at., 2001 b).

Evidence is presented here that maternal exposure to BaP inhibits renal
development in offspring via an AHR allele-specific mechanism characterized by
decreases in glomerular and podocyte numbers that compromise

~llomerular

filtration. Thus, the bioavailabity of PAHs presents a ready source for agents that
can modify important early determinants of renal development. Specifically, the
data shown here indicate that BaP exposures of 0.1 and 0.5 mg/kg inhibit murine
nephrogenesis specifically in C57 but not D2N mice. These findings are in
agreement with previous work demonstrating that repeated exposure to
environmentally-relevant concentrations of BaP inhibit nephrogenesis of murine
metanephric cultures as evidenced by decreases in the number of renal
differentiated structures and molecular markers of cell differentiation
(Falahatpisheh and Ramos, 2003; Nanez and Ramos, 2007). Classical studies
used gross endpoints such as fertility, fetal resorptions, death and severe
developmental gonadal and immune deficits (Harrison et a/., 1994; Lummus and
Henningsen, 1995; MacKenzie and Angevine, 1981a; Nicol et a/., 1995;
Rodriquez et a/., 11999; Wells et a/., 199"7; Winn and Wells, 1997). While our
exposure regimen did not result in gross embryonic deficiencies, as measured by
resorption, death, or morphological organ abnormalities, subtle BaP-induced
differences become manifest as decreased glomerular numbers and
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compromised renal function. These deficits are relevant to the development of
adult onset renal dlisease (Sasaki et al., 2006; Zandi-Nejad et al., 2006).

Our model in which maternal BaP insult results in decreases in podocyte
number that impair glomerular filtration is strikingly similar to clinical
manifestations seen in conditions such as focal segmental glomerulosclerosis
(FSGS) or diabetic nephropathy (Hara et al., 2001; Hayden et a/., 2005; Kim et
al., 2001; Wolf et al., 2005). Podocytes are terminally differentiated cells that line

the glomerular basement membrane (GBM) acting as a filter-mediated sizeselectivity and must structurally encompass the entire glomerular surface with
foot processes to maintain proper filtration (Wiggins, 2007). Podocytopenia
results in denudation of the GBM that compromise glomerular function initiating a
cycle of injury and continued podocyt1e loss leading to progressive renal failure.
In fact, glomerulopathies are the most common causes of end-stage renal
disease worldwide (Hricik et a/., 1998). The impact of in utero BaP exposure on
other glomerular cell populations such as mesangial and endothelial cells
remains to be determined. Of interest, are findings from in vivo studies in female
Sprague-Dawley rats exposed by gavage to weekly 10 mg/kg BaP resulted in
progressive elevations in total urinary protein, protein/creatinine ratios and
microalbuminuria (Nanez et a/., 2005). The nephropathic response involved
early reductions in mesangial cell nurnbers coupled to podocyte injury as
evidenced by effacement of foot prooess1es.
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Of importance to our work is the evidence linking PAH exposures to renal
injury. In humans, strong associations have been reported between occupational
aromatic hydrocarbon exposures and glomerular diseases (Hotz, 1994;
Robertson, 1998), smoking and albuminuria in nondiabetic patients (PintoSietsma et al., 2000), and a higher risk of renal dysfunction and renal cancer
(Sertazzi et al., 1989). Taken together with our findings, PAHs may affect renal
development and may predispose offspring to further injury resulting from
repeated exposure in adulthood.

AHR signaling is implicated in SaP-induced toxicity as D2N mice
expressing the nonresponsive AHRd alle'le are protected from nephrogenic
deficits. Since the AHRd allele is functionally null and SaP-induced deficits
correlate to AHR protein expression, it is likely that loss of the AHR protein and
constitutive signaling regulates nephrogenesis irrespective of nuclear
translocation, association with ARNT, or AHRRE transcriptional activation. AHR
transcriptional activity is regulated by association of complexes including AHRARNT, NF-kappa S, AP-1, and glucocorticoid, all of which participate in
numerous signaling pathways potentially relevant to nephrogenesis. Our work
has identified AHR as a regulator of the 'Nilms' tumor transcription factor, a
master regulator that initiates genetic events regulating early nephrogenesis.
Loss of the AHR through ligand activation, genetic mutation, or siRNA-mediated
degradation results in dysregulation of \NT1 mRNA isoforms and loss of renal cell
differentiation markers (Falahatpisheh and Ramos, 2003; Falahatpisheh and
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Ramos, 2007; Nanez and Ramos, 2007). Recent studies have proposed that
AHR acts as an E3 ligase associatingl with proteasomal complexes consisting of
DDB1, ARNT, TBL3 and CUL4B promoting degradation of sex steroid hormone
receptors (Ohtake et al., 2007). These findings suggest a scenario in which AHR
regulates proteasomal degradation of factors necessary for renal development, a
hypothesis that remains to be tested.

Expression of AHR is conserved across vertebrate and invertebrate
species, many of which are not normally exposed to classical aromatic ligands
(Hahn, 2002; Hahn et al., 2006). Our findings showing a correlation between the
loss of AHR expression and compromised development (Nanez and Ramos,
20(7), are in agreement with deficits seen in AHR-/- mice. However, these
findings are not consistent with decreased levels of AHR protein seen in D2N
mice-treated with BaP in utero. Thus, the nature of molecular signaling events
regulated by AHR remain to be established. Irrespective of this observation, the
collective evidence supports the hypothesis that AHR acts as an important
nuclear transcription factor during embryogenesis and throughout maturity in
multiple organisms. AHR-/- mice exhibit deficits in vascular structures stemming
from a failure of the ductus venosus to close and result in reduced liver weight,
microvesicular fatty metamorphosis, prolonged extramedullary hematopoeisis,
and portal hypercellularity (Fernandez-Salguero et al., 1995; Lahvis et al., 2000;
Lahvis et aI., 2005; Schmidt et al., 1996). Of direct relevance to our studies are
experiments in which AHR-/- mice were found to have cardiac hypertrophy and
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elevated mean arterial pressure, conditions known to arise from compromised
renal function (Lund et aI., 2003; Lund et aI., 2006). We have previously shown
that AHR-/- mice exhibit delayed

nephro~lenesis

development, as evidenced by nephropenia and

resulting in compromised renal
decreasE~s

in renal vasculature

(Falahatpisheh and Ramos, 2003; McMillan and Bradfield, 2007b). Small
interfering RNA (siRNA.) mediated degradation of AHR results in decreases in
renal cell differentiation markers (Falahatpisheh and Ramos, 2007). The
mechanisms by which AHR signaling regulates renal cell differentiation and
nephrogenesis remains poorly understood and, therefore, additional studies are
warranted.
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CHAPTER 3

AHR SIGNALING AND NEPHROGENESIS: A MUTANT AHR ALLELE
PROTECTS THE DEVELOPING KIDNEY FROM HYDROCARBON-INDUCED
DEFICITS IN RENAL CELLULAR DIFFERENTIATION

Summary

The molecular mechanisms governing ontogenesis are regulated by
somatic and environmental factors in utero that activate or repress the
expression of numerous genetic elements. The aryl hydrocarbon receptor (AHH)
is an important ligand-activated nuclear transcription factor involved in the
regulation of cellular differentiation. Environmental hydrocarbons acting as AHH
ligands deregulate receptor signaling to induce deleterious developmental
deficits in several organ systems, including the kidney. Using a metanephric
kidney organ culture system we have shown that benzo(a)pyrene (BaP), an AHR
ligand, inhibits nephrogenesis in embryonic day 11.5 (EII.!)) C57BLl6J (C57)
mouse embryos and alters -KTS/+KTS VVT1 mRNA ratios after a consecutive
four-day exposure. Because WT1 (Wilms' tumor suppressor-1) functions as a

master switch in the

re~Julation

of renal

cE~1I
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differentiation, here we tested the

hypothesis that modulation of AHR signaling by SaP medilates changes in WT1
splice variant ratios and expression of downstream effectors of WT1 leading to
deficits in nephrogenesis. The data show that altered WT1 mRNA ratios in
C57SLl6J mice expressing the AHRb allele correlated with a reduction in the
mRNAs of multiple WT1 transcriptional targets (Synd1, Pax2, Egfr and Rara), as
well as downstream markers of renal cell differentiation (Sfrp1, Igf1 r, Igf2r, Wnt4,
Lhx1, and E-·cad). Metanephroi from S6.D2N-AHRd/J mice expressing an AHFt
variant allele of reduced ligand-binding affinity were spared deficits in renal cell
differentiation following SaP treatment. \Ne conclude that SaP disrupts
nephrogenesis in vivo by altering the expression of downstream Wf1 targets
secondary to changes in the abundance of WT1 mRNA slPlice variants. These
findings establish a link between WT1 and AHR signaling in the regulation of
renal cell differentiation during the course of metanephric development.

Introduction

Embryonic development requires orchestration of temporally precise
genetic events that culminate in the formation of a complete organism. The
molecular mechanisms responsible for ontogenesis are regulated by
environmental and somatic factors in utero that activate or repress the
expression of numerous genetic elements. Recent studies have identified the
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aryll hydrocarbon receptor (AHR) as an important nuclear transcription 'factor
during embryogenesis and throughout maturity in multiple organisms. AHR is
involved in the regulation of development of vascular structures and liver
(Fernandez-Salguero et a/., 1995; Lahvis et a/., 2005; Schmidt et a/., 1996), with
AHR-/- exhibiting cardiomegaly and hypertension, as well as renal and ocular
deficits (Falahatpisheh and Ramos, 2003; Fernandez-Sallguero et a/., 1997; Lund

et a/., 2003; Lund et a/., 2006; McMillan and Bradfield, 2007b). The discovery of
endogenous substrates of AHR has further strengthened the hypothesis that
AHR functions as a critical developmental regulator (McMillan and Bradfield,
2007a). Potent environmental chemicals. acting as AHR ligands disrupt normal
signaling to exert deleterious effects during embryonic development (Mackenzie
and Angevine, 1981b; Ng et a/., 2006b; Ng et a/., 2006c; Shum et al., 1979; Yu et

a/.,2(06). While the mechanism of AHR-mediated regulation of xenobiotic
metabolism is well understood, the details of AHR function during development
remain unclear.

AHR is a transcription factor activated by hydrophobic aromatic
hydrocarbons. Upon ligand binding, AHR dissociates from two molecules of the
chaperone heat shock protein 90 (HSP90), and binds the X-associated protein 2
(XAP2) and p32. The resulting complex exposes a nuclear localization sequence
that facilitates nuclear translocation. This complex in turn binds to the aryl
hydrocarbon receptor nuclear translocator (ARNT or HIF'l~) resulting in DNA
binding to sequences containing 5'-GCGGGGGCG-3' and (TCC)n repeats
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(Denison and Nagy, 2003). Translocation of the AHR-ligand complex to the
nucleus triggers its proteolytic degradation regardless of ARNT binding (Roberts
and VVhitelaw, 1999). AHR is also regulated by negative feedback inhibition in
which the nuclear AHR complex activates transcription of the AHR repressor
protein (AHRR) responsible for binding the xenobiotic response element (XRE)
and preventing transcriptional activation by AHR (Mimura et al., 1999).

A role for AHR in renal development was established in experiments
showing that AHR-null mice exhibit deficits in renal condensation, appearance of
differentiated structures and cellular proliferation (Falahatpisheh and Ramos,
2007). Renal development proceeds in three morphologically distinguishable
stages pronephros, mesonephros, and metanephros (Pohl et al., 2000). The
kidney derives from the nephric ridge in the intermediate

mE~soderm.

The

pronephric duct gives rise to the pronephros which elongates to form the Wolffian
duct. The Wolffian duct develops into the ureteric bud setting thE! stage for the
key event in nephrogenesis where mesonephric mesenchyme is stimulated to
undergo condensation and mesenchymad-to-epithelial cell transition. A host of
genes including, WT1, glial cell derived neuronal factor (GDNF) and bone
morphogenic protein-7, are responsible for regulating this process (Kuure et aI.,
2000). While removing anyone of a host of proteins can result in impaired
nephrogenesis, the molecular mechanisms involved haVE! yet to be fully
characterized.
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Of interest is the central role of Wilms' tumor suppressor gene (WT1) in
nephrogenesis. WT1 encodes a Cis r His 2 zinc fingered protein that functions via
transcriptional regulation of target genes, including insulin-like growth factor II,
syndecan-1, epidermal growth factor receptor and retinoic acid receptor-a
(Hosono et aI., 1999). In addition to its role in tumorigenesis, WT1 is considered
a "master switch" that regulates mesenchymal-to-epithelial differentiation during
renal development (Avner, 1993). Visceral epithelial cells (podocytes) are the
only cell type in adult kidney that retains 'WT1 expression. Homozygous WT1 -/mice do not develop normally, die in utero, and do not show differentiation of
metanephric kidney from the existing pronephros

(Kreidber~l

et aI'., 1993b). WT1

activity can be regulated in cis by different ratios of its own splice variants, or in
trans by proteins such as bone marrow zinc finger 2 (BMZF:2) (Lee et al., 2002).

Perhaps the most studied regulatory mechanism involves the formation of WT1
±KTS splice variants. KTS splice variants originate from the insertion of a Iysinethreonine-serine between the third and fourth zinc finger. The resulting change
modifies the WT1 DNA binding specificity leading to activation and/or repression
of target genes (Menke et al., 1998b). In humans, reduced WT1 +KTS mRNA
isoforms result in severe kidney and gonad developmental deficits, collectively
known as Frasier syndrome (Barbaux et al., 1997). Changes in exon 5 splice
variants have also been associated with deficits in renal differentiation (Iben and
Royer-Pokora, 1999). Addition of 17 amino acids in exon 5 creates an mRNA
isoform that regulates transactivation (Wang et al., 1995). N-terminal residues 1-
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182 encode a dimerization region implicated in the regulatory mechanism
exerted by dominant negative mutants (Englert et aI., 19915; Reddy et al., 1995).

The regulation of renal cell differentiation is controlled by synchronized
expression of multiple genes involved in control of the devellopmental
programming. Sfrp1 is a mesenchymal marker expressed in the metanephric
medullary and cortical stroma that acts as an inhibitor of the mesenchymal-toepithelial cell transition (Yoshino et al., 2001a). Igf2r is chiefly expressed during
the early stages of nephrogenesis whereas Igf1 r is expressed ubiquitously
throughout renal maturation (Dong Van Huyen et aI., 2003). Loss of function of
either receptor compromises renal differentiation (Feld and Hirschberg, 1996).
Wnt4 is expressed in the condensed mesenchyme specifically around the ureter
tip and in pretubular aggregates (for review see (Vainio et al., 1999). Wnt4
deficiency inhibits epithelial tubule development resulting in dysfunctional
nephrons (Stark et a/., 1994). Lim-1 is a homeobox transcription factor essential
for early kidney morphogenesis. Lim-1 is chiefly expressed in the ureteric bud,
induced mesenchymal aggregates, and differentiated structures (comma and Sshaped bodies) (Barnes et al., 1994; Karavanov et al., 1SI98). Murine models
with Lim-1 deficiency are born headless and without kidneys despite the
presence of other organs (Shawlot and Behringer, 1995b). E-cad is a general
marker of the mesenchymal-to-epithelial cellular transition and is expressed in
the ureteric bud epithelium, distal tubule progenitor cells and the majority of
differentiated tubular epithelium (Cho et al., 1998).
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The present study was conducted to evaluate the role of AHR signaling in
murine nephrogenesis. This work builds upon previous studies establishing a
novel link between AHR and post-transcl'iptional regulation of WT1
(Falahatpisheh and Ramos, 2003). Evidence is presented that the low affinity
AHRd allele abrogates BaP-induced molecular changes in the developing kidney,
including changes in WT1 splicing and expression of WT1 downstream effectors
involved in regulation of renal cell differentiation.

Methods

Metanephric Culture
Day 11.5 mouse embryos were surgically dissected from C57BLl6J AHRb
wild type and B6.D2N-AHRd/J mice. Embryonic kidneys were dissected and
cultured on 0.45 mm polyethylene trephalate cyclopore cell culture inserts
(Fisher) for 1-4 days. The use of transparent membranes allowed for direct
visualization of tissue by phase contrast microscopy. Kidney explants were
maintained at the liquid-gas interface in a solution consisting of a 1: 1 mixture of
Dulbecco's modified Eagle's medium (DIMEM) and F12 supplemented with 10%
fetal bovine serum (FBS) and a 5X concentration of MITO serum extender
(Becton Dickinson, Bedford MA). Explants were allowed to equilibrate for 1 day
before initiation of experiments. Seven or more embryonic kidney explants from
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4 dams were placed on individual inserts and exposed daily to 3 iJM BaP or an
equivalent volume of DMSO with or without 20 nM a-napthoflavone for 1, 3, and
4 days. The 3 iJM BaP dose is an environmentally relevant exposure that
provides optimum activation of the AHR receptor (Bowes and Ramos, 1994). At
the end of each time point, the explants were fixed in situ for evaluation.

Cell culture

mK4 cells were cultured in DMEIVI (Cellgro) supplE!mented with 10% fetal
bovine serum (Atlanta Biologicals) and 1% antibiotic-antimycotic (Gibco). Cells
were seeded at staggered time intervals at an initial density of 40 cells/mm2 to
adjust final densities in culture. After equilibration for 24 hours, cells were
exposed 3 iJM BaP or DMSO for 9, 15, or 51 hours.

Histology and Morphometric Analysisi

Metanephroi were fixed in 4% paraformaldehyde at 4°C for 16 hours,
immobilized in Histogel (Richard Allen Scientific) and embedded in paraffin. 4
iJm serial sections were cut and processed for modified hematoxylin and eosin
staining allowing for visualization of differentiated structures. Images of at least 5
metanephroi per treatment group were eaptured at 5X with an Axiovert 200
inverted microscope (Zeiss) and stored as .zvi files. Glomeruli, S-shaped, and
comma-shaped bodies were quantified using manual functions on Axiovision Rei
4.1 (Zeiss).
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ImmunohistochE~mistry

AHR was detected using a rabbit polyclonal antibody (B-1) (Biomol)
applied overnight at 4°C in a solution containing 0.3% Triton X and 10% goat
serum (Vector Laboratories). Primary antibody was detected using a goat antirabbit biotinylated secondary antibody (Molecular Probes), amplified with
ABCelite®, developed with DAB, and counterstained with Mayer's Hematoxylin
(Vector Laboratories).

Quantitative peR

Total RNA was extracted using TRlzol® and cDNA was synthesized using
SuperScript II (Invitrogen, Carlsbad, CA) as per manufacturer's instructions.
Quantitative PCR using primers specific for WT1 isoforms was performed to
detect differences in the ratio of WT1 splice variants (±KTS) in response to AHR
ligand treatment (Falahatpisheh and Ramos, 2003; Falahatpisheh and
2007). A" other primers were designed using Beacon

DE~signer

f~amos,

5.1 to create

amplicons from 150-300 base pairs with an average meltling temperature of
55°C.

si RNA

Ambion Silencer Pre-designed

siF~NA

for AHR (162529 and 88685), WT1

(18990 and 100360), and a scrambled negative control (#4635) were transfected
using Fugene 6 (Roche, Indianapolis, IN). Briefly, 150 nM of each specific siRNA

was incubated with transfection reagent daily and applied to cells seeded at a
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density of 60 cells/mm2 for three days. Seventy-two hours after treatment, cells
were harvested in situ for further analysis.

Statistical Analysis

Statistical significance was determined using Students t-test, ANOVA,
Wilcoxon Rank Sums, LSD, and Tukey post hoc tests at the p<O.05 level.

Results

Deficits in metanephric differentiation by BaP are linked to AHR

si~lnaling

The activation of AHR signaling by BaP culminates in transcriptional
activation/repression of target genes, and proteasomal

dE~gradation

of AHR

protein (for reviews see (Denison and Nagy, 2003; Fujii-Kuriyama and Mimura,
2005; Pocar et aI., 2005). To examine the role of AHR

si~Jnaling

in Bap··induced

deficits in nephrogenesis, metanephric explants from C57'-AHRb (C57) and D2NAHRd (D2N) mice were challenged with 3 ~M BaP for 1, 3, or 4 days. C57 and
D2N mice are isogenic strains that differ in AHR ligand binding affinity due to a
single nucleotide substitution that replaces valine for alanine at codon 3'75 in the
ligand binding domain resulting in a 5-fold reduction in ligand binding affinity
(Poland et a/., 1994). Quantitative reverse transcriptase polymerase chain
reaction (QRT-PCR) analysis of C57 metanephroi revealed time-dependent
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induction of Cyp1a1 mRNA, while D2N metanephroi expressing the variant AHR
allele showed a markedly abrogated response (Table 1). A 4-day BaP exposure
resulted in compromised metanephric development (Figure 1A), as evidenced by
decreased number of glomeruli (Figure 1B), and predominance of lesser
differentiated, comma and S-shaped bodies (Figure 1C). To determine if ligandbinding mediated deficits in renal cell differentiation, D2N mice expressing the
AHRd allele, or a-napthoflavone (a-NF), a competitive inhibitor of the AHR ligand
binding site, were tested. Interference with AHR-ligand interactions prevented
BaP-induced deficits in renal differentiation. a-NF alone modulated renal
development outcomes (Figlure 1B). Immunohistochemical analysis showed a
decrease in AHR protein after 4 days of BaP exposure in AHRb mice (Figures 2A
& B). In sharp contrast, the abundance of AHRd was not influenced by

hydrocarbon treatment (Figure 2A). The AHRd phenotype, or co-treatment with
a-NF, prevented the loss of AHR protein, suggesting that modulation of
nephrogenesis by BaP directly correlates with depletion of AHR protein. This
finding is consistent with the hypothesis that AHR is required for renal
developmental signaling, and that disruption of nephrogenesis requires AHR
ligand binding, activation of AHR signaling, and protein degradation.

Next, the expression of mesenchymal (Sfrp1) and epithelial (lgf1 r, Wnt4,
Lhx1, and E-cad) markers of differentiation was monitored by QRT-PCR~ to
determine if morphological deficits correlated with modulation of these genes.
Markers of renal epithelial cell differentiation (lgf1 r, Wnt4, Lhx1, and E-cad) were
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Table 1. E 11.5 metanephroi were resected from C57 and D2N-AHRd mllce and
cultured on 0.45

~rn

inserts for 4 days in the presence of 3

~M

BaP or DMSO. At

1, 3, and 4 days individual metanephroi were homogenized and processed for
RNA isolation and cDNA synthesis. Quantitative peR was performed with
values representing i1i1CT normalized fold change relative to DMSO control
(dashed line). Variance represents standard deviation between no less than 6
metanephroi per group. Statistical significance was calculated using a VVilcoxon
rank sum. Cyp1 a1 mRNA was inudced.in a dose and time-dependent manner in
both C57 and D2N mice but to a greater extent in C57.
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Table 1. Cyp1a1 mRNA Expression
Normalized fold change
Exposure (days)

C57

DBA

Irelative to DMSO Control

1

154.34 ± 20.8

3

455.09 ± 30.62

4

730.00 ± 24.00

1

1.82 ± 0.27

3

12.44 ± 2.03

4

39.49 ± 1.20
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Figure 1. SaP inhibits nephrogenesis via an AHR

alleh~-specific

mechanism. E 11.5 (days post conception) metanephroi were resected from
C57 and 02N-AHR d mice and cultured on 0.45 IJm inserts for 4 days in the
presence of 3 IJM SaP or OI\llSO

± a-NF. At 4 days, metanephroi were fixed in

4% paraformaldehyde and processed for modified hematoxylin and eosin
staining to visualize differentiated structures. Panel A, BaP-exposed
metanephroi show less morphologically distinct differentiated structures
compared to C57 control. E)(pression of the AHRd allele in D2N mice abrogates
BaP-induced deficits. Co-treatment with the competitive inhibitor a-NF also
inhibited BaP effects. B, quantitation of number of glomeruli normalized to area
from serial sections of no less than 6 metanephroi per group. C, quantitiation of
comma and S-shaped bodies normalized to area. Statistical significance was
calculated by ANOVA and LSD post hoc tests at a p < 0.05 level.
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D2~~

Figure 2. AHR expression correlates with nephrogenesis. E 11.5
metanephroi were resected from C57 and D2N-AHR d mice and cultured on 0.45
IJm inserts for 4 days in the presence of 3 IJM BaP or DMSO ± a-NF. At 4 days,
metanephroi were fixed in 4% parafomaldeyde and processed for modified
hematoxylin and eosin staining, to visualize differentiated structures. Serial
sections were processed for immunohistochemical analysis of AHR protein and
counterstained with hematoxylin. AHR

si~lnal

was calculated by creating a

thresholded value for AHR signal accounting for nonspecific signal from negative
control serial sections processed without primary antibody and primary antibody
neutralized with blocking peptide. Sum density was normalized to area and
statistical significance was calculated by ANOVA and LSD post hoc tests p <
0.05. Panels A and B show that exposure tD BaP decreases AHR protein levels.
Protein expression was similar in C57' and D2N metanephroi, however D2N or
NF co-treated metanephroi were not sensitive to BaP-induced deficits in AHR

protein expression.
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D2N

induced to varying degrees relative to vehicle control after 1 day of BaP exposure
(Figure 3A). In C57' metanephroi, Igf1 r,

l~lf2r,

Wnt4, Lhx1, and E-cad mRNA

levels were decreased after 3 and 4 days of BaP treatment (Figure 3A) . No timedependent changes in the expression of the mesenchymal marker Sfrp1 were
seen in C57 mice where downregulation was seen at all time-points compared to
vehicle (Figure 3A). Metanephroi expressin!~ the AHRd allele showed variable
degrees of induction in Sfrp1, Igf1 r, Wnt4. and E-cad throughout the exposure
and were spared reductions of all markers examined, except Lhx1 (Figure 3B).
These results suggest that nephrogenic deficits induced by BaP require
activation, and integrity, of AHR signaling.

The AHR allele mediates disruption of WT1 mRNA splice variants by BaP
Previous work established that exposure of C57 mouse metanephric
kidney cultures to BaP for 4 days modulaltes the expression of -KTS/+KTS WT1
mRNA variants (Falahatpisheh and Ramos, 2003). A 4-day BaP exposure of

C5t' metanephroi

rE~sulted

in 3- and 7-fold induction of +KTS and -KTS variants,

respectively (Figures 4A and B). Expression of the +17aa or -17aa was not
altered by BaP treatment (Figures 4C and D). Consistent with the known WT1
transcriptional repressive activity, significant reductions in the relative expression
of several WT1 targets including: Synd1, Pax2, Egfr, and Rara, were observed
(Figure 4E). D2N-AHRd metanephroi exposed to 3 IJM BaP did not exhibit
changes in any of the VVT1 mRNA splice variants (Figures 5A-D) or WT1 targets
(Figure 5E), except for Rara where the pattern of gene re~lulation was reversed
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Figure 3. BaP exposure downregulatel; markers of renal cell differentiation.
E 1 '1.5 metanephroi were resected from C57" and D2N-AHR d mice and cultured
on 0.45 IJm inserts for 4 days in the presence of 3 IJM BaP or DMSO. At 1, 3,
and 4 days individual metanephroi were homogenized and processed for RNA
isolation and cDNA synthesis. Quantitative PCR was performed with values
representing

.~~CT

normalized fold change relative to DMSO control (dashed

line). Variance represents standard deviation between no less than 6
metanephroi per group. Statistical significance was calculated usinn a Wilcoxon
rank sum. Panels A and B show, that at 4 days BaP exposure, significant
decreases in differentiation markers were seen in C57, but not in
metanephroi.
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Figure 4. BaP-induced WT1 dysregulation correlates with loss of known
WT1 targets. E 11 . 5 metanephroi were resected from C57 mice and cultured on
0.45 I-lm inserts for 4 days in the presence of 3 I-lM BaP or DMSO. On days 1, 3,
and 4, individual metanephroi were homolgenized and processed for RNA
isolation and cDNA synthesis. Quantitative peR was performed with values
representing

~~CT -normalized

fold changle relative to DMSO control (dashed

line). Variance represents standard deviation between no less than 6
metanephroi per group. Statistical significance was calculated using a Wilcoxon
rank sum. Panels A-D, primers specific for each splice were used to compare the
abundance of splice variants from BaP treated and DMSO control samples. No
changes were seen in total WT1 mRNA expression. Panels A and B, Significant
increases were seen in -KTS compared to +KTS after 4 days BaP exposure.
Panels C and 0, no significant changes were seen in +17aa or -17aa isoforms.
Panel E shows that downregulation of known \NT1 targets correlated with
changes in WT1 isoform abundance.
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Figure 5. SaP-induced WT1 dysregulation is AHR allele-specific. E 11.5
metanephroi were resected from D2N-AHRd mice and cultured on 0.45 I-lm
inserts for 4 days in the presence of 3 I-lM BaP or DMSO. On days 1, 3, and 4,
individual metanephroi were homogenized and processed for RNA isolation and
cDNA synthesis. Quantitative PCR was performed with values representing
L1L1CT-normalized fold change relative to DMSO control (dashed line). Variance
represents standard deviation between no less than 6 metanephroi per group.
Statistical significance was calculated using a Wilcoxon rank sum. Panels A-D,
primers specific for each splice were used to compare the abundance of splice
variants from BaP treated and DMSO control samples. No changes were seen in
total WT1 mRNA expression. Panels A - D, expression of the AHRd allele
abrogates BaP-induced modulation of WT1 mRNA isoforrns in D2N mice. Panel
E, downregulation of known WT1 targets correlates with changes in WT1 isoform
abundance.
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compared to the C57 strain. C57 metanephroi exhibited decreases in taurine
transporter mRNA and these: changes were absent in D2N metanephroi exposed
to BaP (compare Figures 4E and 5E).

mK4 metanephric cells arE! sensitive

tOI

modulation of WT1 mRNA isoforms

by SaP and other AHR ligcmds
To develop a model amenable to molecular manipulation, mouse mK4
cells derived from metanephric tissue WE~re exposed to 3 I-lM BaP as a function
of time (Valerius et al., 2002). mK4 cells exhibited time-dependent induction of
Cyp1 a1, with maximal effeclts seen 51 hr after hydrocarbon exposure (Figure
6A). Sfrp1, Igf1 r, Igf2r, Wnt4, and E-cad were downregulated by BaP as a
function of time (Figure 6B), with the most prominent effects seen for Sfrp1, Igf1 r,
Wnt4 and E-cad. Interestinlgly, Sfrp1 and Lhx1, markers of the mesenchymal
phenotype contain AHR response elements in their promoter regions (data not
shown), and showed a biphasic response. Changes in markers of renal cell
differentiation correlated with changes in +KTS and -KTS where 2- and 5-fold
inductions in mRNA expression, respecbvely, were observed (Figures 7A and B).
The expression of the +17aa isoform exhibited a biphasic response, with
induction seen at 9 and 15 hours and a return to baseline at 51 hours (Figures
7C and D). As in the metanephric model, AHR protein loss (Figure 7E) and
dysregulation of WT1 splice variants correlated with reductions in WT1 target
mRNAs, as evidenced by reductions in Pax2, Egfr, and Rara at 51 hours of BaP
exposure (Figures 7F).
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Figure 6. mK4 cells are sensitive to BaP induced changes in differentiation
markers. mK4 cells were seeded and exposed at various times to 3

~M

BaP or DMSO

to allow for harvest at equal density. At 9,15, and 51 hours cells were processed for
RNA isolation and cDNA synthesis. Quantitative PCR was performed with values
respresenting

~~CT-normalized

fold change relative to DMSO control (dashed line).

Variance represents standard deviation amongst at least three biological replicates.
Statistical significance was calculated using a Wilcoxon rank sum. Panel A shows that
mK4 cells display classical CYPIAI profile induction with a maximal response at 51
hours. Panel B shows that after 51 hours of BaP exposure mK4 cells downregulated
markers of differentiation.
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Figure 7. mK4 cells are sensitive to BaP induced modulation of WT1
status. mK4 cells were seeded and exposed at various times to 3 IJM BaP or
DMSO to allow for harvest at equal density. At 9, 15, and 51 hours cells were
processed for RNA isolation and cDNA synthesis. Quantitative PCR was
performed with values representing

~~CT -normalized

fold change relative to

DMSO control (dashed line). Variance represents standard deviation amongst at
least three biological replicates. Statistical significance was calculated using a
Wilcoxon rank sum. Panels A and B, 51 hours of BaP exposure induces -KTS.
Panels C and D, +17aa is increased at 9 and 15 hours. Panel E, Western blot
analysis of WT1 targets shows loss of protein for known \/\'T1 markers. Panel F,
Inductions in -KTS WT1 mRNA isoform correlate with decreases in WT1 targets.
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51

To determine if nephrogenic deficits were seen with other AHR ligands,
mK4 cells were challenged with varying concentrations of TeOO ranging from 0.1
pM to 1 nM for 4S hours. Integrity of AHR signaling was confirmed by induction
of eyp1a1 mRNA (Figure SA). Both 100 pM and 1 nM TeDO decreased AHR
protein (Figures SB and e). Exposure to 100 pM TeOO reduced expression of
differentiation markers Sfrp1, Igf1 r, Igf2r, and Wnt4 (Figure SO). The loss of
differentiation markers correlated with altered expression of WT1 splice variants
(Figure SE). WT1 target genes, Synd1, Pax2, Egfr, and Rara were also
downregulated by TeOO exposure (Figure SF).

Discussion

Evidence continues to mount implicating AHR in proliferation,
development, adhesion and migration, and proteasomal degradation (for reviews
see (Barouki et al., 2007; Ohtake et aI., 2007)). In this regard, previous studies
in this laboratory have shown that repeated exposure of cultured metanephros to
3 IJM BaP results in significant impairment of metanephric development
(Falahatpisheh and Ramos, 2003). Such deficits required AHR activation and
appears to be linked to the protein degradation machinery of target cells in the
developing kidney. While the E3 ligase activity of AHR has yet to be fully
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Figure 8. Alternative AHR ligands moderate differentiation markers and
WT1 status. mK4 cells were seeded and exposed to TCDD or vehicle for 51
hours to allow for harvest at equal density. Cells were processed for RNA
isolation, cDNA synthesis and protein analysis. Quantitative PCR was performed
with values representing 1'11'1CT normalized fold change relative to OM SO control
(dashed line). Variance represents standard deviation amongst at least three
biological replicates. Statistical significance was calculated using a Wilcoxon
rank sum. Panel A, dose-dependent Cyp1a1 mRNA inductlion. Panels Band C,
western blot analysis reveals a dose-dependent loss of AHR protein. Panel 0,
TCDD exposure results in loss of renal cell differentiation markers. Panel E,
+17aa WT1 mRNA is induced. Panel F, WT1 dysregulation correlates to loss of
WT1 targets.
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characterized (Ohtake et al., 2007), AHR ubiquitination and degradation can
occur both in the cytoplasm (Song and Pollenz, 2002), or upon nuclear
translocation (Roberts and Whitelaw, 1999), and ARNT/ONA binding (Song and
Pollenz, 2003). Mutation of the ligand binding domain in the AHRd allele
decreases ligand binding affinity by 5-fold compared to AHRb and decreases
nuclear translocation (Poland et a/., 1994), transcriptional activation and
degradation upon ligand binding. Similarly, AHR antagonists, such as a-NF, do
not induce the conformational changes necessary for translocation and/or
degradation of AHRb (Henry and Gasiewicz, 2003). These relationships define a
scenario in which constitutive AHR plays a regulatory role in renal development
that is compromised upon ligand-mediated degradation of receptor protein. In
fact, AHR-null mice exhibit delayed nephrogenesis and compromised renal
development (Falahatpisheh and Ramos, 2003), and these changes can be
reproduced by downregulation of AHR protein upon ligand binding. Of
importance to the work presented here are studies in which AHR-null mice were
found to be hypertensive, a condition that is directly related to deficits in renal
function (Lund et al., 2003; Lund et aI., 2006).

Our model detailing a constitutive function for AHR in regulation of
nephrogenesis via WT1 is supported by the finding that prevention of AHR loss
pharmacologically, or by the use of the genetically-resistant 02N strain,
prevented renal developmental deficits in BaP-treated metanephros, and
restored normal ratios of WT1 mRNA isoforms.. Mice overexpressing the -KTS
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isoform have severely compromised renal development, evidenced by increased
stromal tissue, decreases in tubular epithelium and glomerular tuft, and altered
podocyte structure (Hammes et a/., 2001). While the exact molecular
consequences resulting from alterations of the four abundant and biologically
relevant isoforms of WT1 remain to be fully defined, it is well-established that the
-KTS mRNA encodes a protein that participates in transcriptional activity, and
that protein encoding +KTS mRNA associates with splicing factors (Davies et al.,
1998; Hastie, 2001). In both metanephros and mK4 cell cultures, BaP-induced
increases in -KTS resulted in downregulation of differentiation markers, a finding
consistent with the morphological deficits seen in -KTS transgenic mice.
Restoring WT1 mRNA splice variant ratios via AHRd expression did not alter
renal differentiation markers. Transgenic mice expressing solely +17aa WT1 do
not exhibit gross renal nephropathy (Natoli et al., 2002), but have deficits in other
organ systems such as the olfactory system (V'Jagner et al., 2005).

The complexity of AHR functions in different transcriptional complexes
such as the classical AHR- ARNT, NF-kappa B, AP-1, and

!~Iucocorticoid

receptor provides possible mechanisms for regulation of Wr1 splicing. Of these,
the glucocorticoid receptor has been shown to associate with PGC-1, a known
regulator of co-transcriptional splicing (Knutti et al., 2001). Another possibility
involves direct binding of AHR to the WT1 promoter which contains two
consensus AHR responsive elements within a regulatory region known to
regulate transcription-coupled splicing events (Cohen et al., 1997). Ongoing
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experiments are examining whether AHR binds to the WT1 promoter to alter the
splicing machinery directly (Bentley, 2002), or indirectly by altering elongation
efficiency (Eperon et al., 1988; Roberts et al., 1998). Because AHR itself
associates with proteasomal complexes consisting of DDB1, ARNT, TBL3 and
CUL4B, and has E3 ligase activity (Ohtake et al., 2007), AHR may also regulate
proteasomal degradation of factors required for WT1 splicing.

The reduction of selected renal differentiation markers seen in organ and
cell culture is consistent with the loss of AHR protein mediated by BaP, TCDD, or
small interfering RNA (data not shown). All markers examined play central roles
in nephrogenesis. Lhx1-null mice do not progress past mesonephric
development (Shawlot and Behringer, 1995a). Wnt4 is implicated in early
nephron development and differentiation (Stark et aI., 1994). Inhibition of the
Igf1 r impairs kidney growth, as evidenced by a reduction in nephrons and altered
ureteric bud branching (Murphy and Barron, 1993; Wada et al., 1993). E-cad-null
mice have decreased nephron number due to a failure of proper fusion of the
metanephric mesenchyme to the ureteric bud (Mah et al., 2(00). Sfrp1, most
likely through Wnt interactions, plays an important role in the mesenchymal to
epithelial cell transition manifested during tubule formation and bud branching
(Yoshino et a/., 2001 b). While these markers have yet to be examined in AHRnull mice, the preservation of AHR expression and constitutive signaling via
expression of AHRd or treatment with antagonist, restores their expression.
These findings associate functional molecular consequences resulting from
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disruption of constitutive AHR functions with the regulation of renal cell
differentiation.

The discovery of novel functions of AHR during nephrogenesis, coupled to
molecular interactions of AHR with WT1, highlight a potential mechanism for
compromised renal development following AHR signaling interference. The
bioavailability of PAHs presents a ready source for agents that can modify
important early determinants of renal cell differentiation. Of importance to our
work are studies linking AHR genetic polymorph isms to tobacco smoke induceddecreases in birth weight (Sasaki et a/. , 2006). Low birth weight compromises
renal development resulting in increases in microalbuminuria, proteinuria,
decreased glomerular filtration rate, and the occurrence of end stage renal
disease (for review see (Zandi-Nejad et al., 2006)). Other stressors, such as diet
and environmental exposures, are associated with lower birlth weights and
deficits in renal development (Everson et al., 1988; Nelson ot al., 1999; Roquer
et al., 1995; Zandi-Nejad et al., 2006). Preliminary findings indicate that

exposure of pregnant C57 dams to BaP to environmentally-relevant
concentrations, inhibits renal development (Nanez, et ai, unpublished).

The present studies identify a novel role for AHR in the regulation of
murine nephrogenesis. Expression of the AHRd allele preserves the integrity of
AHR signaling and abrogates hydrocarbon-induced dysregulation of WT1 mRNA
isoforms thus preserving renal cell differentiation signals. Thus, endogenous and
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exogenous modulators of AHR signaling during critical periods of nephrogenesis
may alter the genetic programming of renal development.

11 1

CHAPTER 4

LOSS OF THE ARYL HYDROCARBON RECEPTOR PROTEIN ALTERS WT1
mRNA ISOFORM EXPRESSION AND DOWNSTREAM EFFECTORS OF
RENAL CELL DIFFERENTIATION

Summary

A key event in nephrogenesis is the transdifferentiation of mesenchymal
cells to epithelial cells, a tightly regulated process controlled by the Wilms' tumor
transcription factor (WT1). WT1 activity can be regulated in cis by different ratios
of its mRNA splice variants, or in trans by accessory proteins recruited to
regulatory regions of the gene. Recently, a novel link between AHR and posttranscriptional regulation of WT1 isoform expression was characterized in this
laboratory. The aryl hydrocarbon receptor (AHR) is an important ligand-activated
nuclear transcription factor involved in the regulation of cellular differentiation.
AHR-null mice exhibit systemic developmental deficits including nephropenia.
Previous work has shown that exposure to environmental hydrocarbons that
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function as AHR ligands deregulate receptor signaling via proteasomal
degradation and induce receptor-specific deregulation of WT1 mRNA splice
variant ratios in murine metanephric organ and cell. This work led us to
hypothesize that disruption of receptor signaling following loss of AHR protein
results in WT1 dysregulation thereby altering expression of WT1 targets and
renal cell differentiation genes. Evidence is presented here showing that AHR
degradation mediated by small interfering RNA results in downregulation of +KTS
and induction of the -KTS mRNA splice variants. WT1 dysregulation correlates
with reductions in WT1 transcriptional targets (Synd1 Pax2, Egfr and Rara), as
well as downstream markers of r€!nal cell differentiation (Sfrp1, Igf1 r, Igf2r, Wnt4,
Lhx1, and E-cad). We conclude that AHR regulation of nephrogenesis occurs
through preservation of WT1 mRNA isoform ratios within the kidney.

Introduction

The aryl hydrocarbon receptor (AHR) is a member of the basic helix loop
helix Per ARNT Sim (bHLH-PAS) family of transcription factors and initially
characterized for its role in the

re!~ulation

of xenobiotic metabolizing enzymes

(XMEs) necessary for removal of exogenous chemicals. VVhile bHLH-PAS
proteins share similar structure and function, the AHR is the only member of the
family known to be regulated by ligand activation. Environmental chemicals such
as polycyclic aromatic hydrocarbons act as AHR ligands leading to the
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dissociation of two molecules of the chaperone heat shock protein 90 (HSP90),
X-associated protein 2 (XAP2) and p32. The resulting conformational change in
AHR exposes a nuclear localization sequence that facilitates nuclear
translocation. In the nucleus, AHR dissociates from the chaperone complex and
binds the aryl hydrocarbon receptor nuclear translocator (ARNT) resulting in
association of the major groove DNA sequence cantaining 5'-GCGGGGGCG-3'
and (TCC)n repeats (Denison and Nagy, 2003). Translocation of the AHR-ligand
complex to the nucleus can also trigger its proteolytic degradation regardless af
ARNT binding (Roberts and

WhitE~law,

1999). Depending upon cell type, AHR

can be regulated by negative feedback inhibitian in which the nuclear AHR
complex activates transcription of the AHR repressor protein (AHRR) respansible
for binding the xenobiotic response element (XRE) (Mimura et a/., 1999). AHR
transcriptional activity is regulated by association of complexes including AHRARNT, NF-kappa B, AP-1, and glucocorticoid receptor all of which, in turn,
participate in numerous signaling pathways potentially relevant ta nephrogenesis
(Abbatt et al., 1994; Hankinson, 2005; Hoffer et al., 1996; Miller et al., 2000; Tian
et al., 2002).

Of relevance to this study are novel links identifying AHR as a regulator af
the Wilms' tumor transcription factor (WT1), a master switch transcriptianal
regulatar which initiates genetic E~vents necessary for early nephrogenesis
(Scharnhorst et al., 2001). Loss Df the AHR through ligand activation, genetic
mutation, or siRNA-mediated degradation results in dysregulation of WT1 mRNA
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isoforms and loss of renal cell differentiation markers (Falahatpisheh and Ramos,
2003; Falahatpisheh and Ramos, 2007; Nanez and Ramos, 2007). Studies using
AHR -/- mice have led to findings that support the scenario in which AHR acts as
an important nuclear transcription factor during embryogenesis and throughout
maturity in multiple organisms. AHR -/- mice exhibit cardiac hypertrophy and
elevated mean arterial pressure (Lund et aI., 2003; Lund et aI., 2006) that
correlate to inductions in endothelin-1 and angiotensin II, known regulators of
cardiomyocyte hypertrophy and hypertension (Gavras and C3avras, 2002;
Yamazaki et al., 1996). Of relevance to renal biology is that angiotensin II is a
potent renal vasoconstrictor that constricts efferent arterioles and increases
blood pressure. Our laboratory has shown that AHR-null mice exhibit delayed
nephrogenesis resulting in compromised renal development as evidenced by
nephropenia and decreases in renal vasculature (Falahatpisheh and Ramos,
2003; McMillan and Bradfield, 2007b). Thus, it is possible that developmental
renal deficits in AHR -/- mice stem from disruption of AHR signaling implicit in
nephrogenesis.

Nephrogenesis proceeds in three morphologically distinguishable stages
pronephros, mesonephros, and metanephros (Pohl et al., 2000). The precursor
structure for renal development derives from the nephric ridge in the intermediate
mesoderm. The pronephric duct gives rise to the pronephros which elongates to
form the Wolffian duct. The Wolffian duct develops into the ureteric bud
stimulating the mesonephric mesenchyme to undergo condensation and
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transdifferentiate from mesynchemal-to-epithelial cells. A cascade of genetic
events regulated by proteins including WT1, glial cell derived neuronal factor
(GONF) and bone morphogenic protein-7, are responsible for regulating this
process (Kuure et aI., 2000). While homozygous deletion or mutation of either of
these genes impairs nephrogenesis, the molecular mechanisms involved have
yet to be fully characterized.

WT1 encodes a Cis2 -His2 zinc fingered protein that functions via

transcriptional regulation of target genes, including insulin-like growth factor II
(lgf2r), syndecan-1 (Synd1),

epidE~rmal

growth factor receptor (Egfr) and retinoic

acid receptor-a (Rara) in the early stages of renal development (Hosono et al.,
1999). Homozygous WT1-/- mice do not develop normally, die in utero, and fail
to differentiate into metanephric kildney from the existing pronephros (Kreidberg
et al., 1993b) due to a failure of cE~lIs to undergo mesenchymal-to-epithelial

differentiation (Avner, 1993). WT1 protein expression is strongest in the
differentiating structures of the developing kidney; however, visceral epithelial
celis (podocytes) are the only cell type that retains WT1 expression in mature
kidneys.

Of importance to the present work is that WT1 activity is regulated in cis
by different ratios of its own splice variants, or in trans by proteins such as bone
marrow zinc finger 2 (BMZF2) or Pax2 (Lee et a/. , 2002). Perhaps the most
studied regulatory mechanism involves the formation of WT1 +KTS/-KTS splice
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variants. KTS splice variants originate from the insertion of a Iysine-threonineserine between the third and fourth zinc finger. The resulting change modifies
the WT1 DNA binding specificity leading to activation and/or repression of target
genes (Menke et a/., 1998b). In humans, reduced WT1 +KTS mRNA isoforms
result in severe kidney and gonad developmental deficits, collectively known as
Frasier syndrome (Barbaux et aI., 1997). Changes in exon 5 splice variants have
also been associated with deficits in renal differentiation (Iben and Royer-Pokora,
1999). Addition of 17 amino acids in exon 5 creates an mRNA isoform that
regulates transactivation (Wang et aI., 1995). N-terminal residues 1-182 encode
a dimerization region implicated in the regulatory mechanism exerted by
dominant negative mutants (Englert et aI., 1995; Reddy et aI., 1995). We
propose that disruption of AHR

si~Jnaling

resulting from receptor degradation

deregulates WT1 resulting in an induction in the -KTS mRNA splice variant, thus
altering the sequence of genetic events necessary for nephrogenesis.

Evolutionary comparison has shown that the Ahr is conserved across
vertebrate and invertebrate species, many of which are not exposed to classical
aromatic ligands (Hahn, 2002; Hahn et a/., 2006). Evidence is mounting to
support the idea that AHR functions as a key regulator of ontogenesis. In this
study we demonstrate that degradation of the AHR results in dysregulation of WT
mRNA splice variant ratios resulting in downregulation of direct genetic VI/T1
targets and renal cell differentiation markers.
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Methods

Animals/Kidney Harvest

C57BLl6J wild type mice were purchased from Jackson Laboratory (Bar
Harbor, Maine) and placed under standard housing conditions. The care,
breeding, and handling of animals were conducted in accord with NIH guidelines.
Kidneys were resected, fixed in 4(1'0 paraformaldehyde, and embedded in
paraffin.

Immunohistochemistry

WT1 (180) (Santa Cruz Biotechnology, Santa Cruz, CA) and AHR rabbit
polyclonal antibodies (Biomol Research Laboratories Inc., Plymouth Meeting,
PA) were applied overnight at 4°C in a solution containing 0.3% Triton X and
10% goat serum (Vector Laboratories, Burlingame, CA). Primary antibody was
detected using a goat anti-rabbit biotinylated secondary antibody (Molecular
Probes), amplified with ABCelite@, developed with diaminobenzidine (DAB) and
3, 3', 5, 5'-tetramethylbenzidine (TMB), respectively (Vector Laboratories,
Burlingame, CA). Images were captured on a Zeiss Axiovert 300 microscope
using Axiovision Rei 4.3 software interface (Carl Zeiss Inc .. Maple Grove, MN).

Cell Cultures/ siRNA Transfectiion
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mK4 cells were kindly provided by Dr. Stephen Potter (Children's Hospital
Medical Center, Cincinnati, OH). Cells were cultured in Oulbecco's modified
Eagle's medium supplemented with 10% fetal bovine serum. Two different
techniques were used for siRNA knockdown of AHR and v\fT1 targets. 1) mK4
cells were cultured and seeded at 30 cells/mm2 in 6 well plates. Using
OharmaFECT 2, mK4 cells were transfected with 150nM pooled siRNA AHR (10#
L-044066-00-0005), WT1 (10# L040686-01-0005) or nonspecific sequence. After
4 days, cells were harvested for RNA isolation, cONA synthesis, and protein
extraction. 2) Hairpin siRNA was designed using verified Silencer Pre-designed
siRNA directed towards AHR (10#188990) and WT1 (10# 100360). The resulting
structures were cloned into a pSilencer 4.1 CMV hygro vector (Ambion, Austin,
TX) and transfected into mK4 cells using Fugene 6. pSilencer 4.1 CMV hygro
Negative Control (Ambion) was used to measure nonspecific effects. Stalbly
transfected cells were selected for using 800 I-lg/1-l1 hygromycin over a 3 week
period. Cells were harvested for

I~NA

isolation, cONA synthesis, and protein

extraction.

Protein Extraction and Western Analysis
Total protein extraction was performed with M-PER reagent

(Piercl~

Biotechnology, Rockford, IL) as described by the manufacturer. Protein
concentration was normalized to bovine serum albumin and measured by
Bradford analysis. Protein samples were heated at 70°C for 10 minutes and run
on 4-12 % NuPage ® Bis-Tris gels for one hour at 200 volts (Invitrogen,
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Carlsbad, CA). Proteins were transferred to PDVF membranes and probed with
WT1 (180) (Santa Cruz Biotechnology, Santa Cruz, CA) and AHR rabbit
polyclonal antibodies (Biomol Research Laboratories Inc., Plymouth Meeting,
PA). Signal was visualized with secondary antibodies conjugated to horseradish
peroxidase developed by SuperSignal® West Dura (Pierce Biotechnology,
Rockford, IL). Values represent averages of at least three independent
experiments.

RNA Isolation and Real time peR Amplification
Total RNA was extracted from the cells using Trizol® according to
manufacturer's specifications. Reverse transcription of RNA was carried out
using iScript™ cDNA Synthesis Kit (Bio-Rad, Hercules, CA). Real time PCR
amplification was performed using the iCycler Detection System (Bio-Rad,
Hercules, CA). For each run, 25

1-11

of 2X SYBR Supermix (Bio-Rad, Hercules,

CA) and 300 nM for both forward and reverse primers in a total volume of 50

1-11

were mixed. Quantitative PCR using primers specific for WT1 isoforms was
performed to detect differences in the ratio of WT1splice variants (±KTS) as
follows. -KTS forward 5'-AGCTCAAAAGACACCAAAGGAG-3', reverse 5'GGGCTTTTCACCTGTATGAG-3'; +KTS reverse 5'GAAGGGCTTTTCACTTGTTTTAC-3'; -17 aa 5' -CCTGAGGACGCCCTACAG C-3'
reverse 5'-TGTGCCGTGGCCCTTTAAGG-3'; + 17 aa 5'CTGTGCCGTGGTTGCTCTGC-3'. All other primers were designed using
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Beacon Designer 5.1 to create amplicons from 150-300 base pairs with an
average melting temperature of 55°C depicted in Table 1.

Quantification was performed using comparative (LlC T) method as
described by Peinnequin et al. (2004). Briefly, the Cr indicates the fractional
cycle number for which the amount of amplified target reaches a fixed threshold.
This amount is a constant depending on the primer set. The difference (ACT)
between the CT of the target gene (C Tt ) and the reference gene (C Tr ) depends on
the RNA relative copy number between the target and the reference gene. When
the PCR have been properly optimized, the PCR efficiencies are close to one
and the amount of target (X N), normalized to an endogenous reference is given
by the equation: X N= K x T

ilcT

WE~re K is a constant according to the target and

reference primer sets (Lestaevel E~t aI., 2003). The normalization to a calibrator
(188 RNA) allows reduction of the previous equation by removing the constant K.
Under these conditions, the amount of target normalized to an endogenous
reference and relative to a calibrator (XN,c) is given by the equation: XN,c:= ZMCT
where LlLlC T is the difference between the LlC T of the sample and the LlC Tof the
calibrator. The LlC T method is based on i) similar amplification efficiency rates
between target and reference genes and ii) PCR efficiency close to 1.

Matrigel Cell culture
mK4 cells were cultured in Dulbecco's modified Eagle's medium
supplemented with 10% fetal bovine serum and 5X mito serum extender (Becton
121

Table 1: peR Primers
Gene

Forward Primer 5'-3'
Gene
18S
Cyp1a1
Taurine Transporter
Syndecan 1

Forward Primer 5'-3'

Reverse Primer 5'-3'

CGTCTGCCCTATCAACTTTCG

GCCTGCTGCCTTCCTTGG

~CGTGTCAGTAGCCAATGTC

GCATCCAGGGAAGAGTTAGG

CATCCATCGTCATTGTGTC

~GTTGGCAGTGCTAAGG

GAGAAC~AGACTTCACCTTTG

~GCACTTCCTTCCTGTCC

Paired box gene 2 (pax2) IAGGTTTACATCTGGTCTGG

TAGGAAGGACGCTCAAAG

Epidermal growth factor
GAGGAGGAGAGGAGAACTG

GGTGGGCAGGTGTCTTTG

CCCAGAAGACTAAAGTTGAC

~GGCAGGTAGTTGTGATG

GCAGTTCTTCGGCTTCTA

ATGGAGGACACACGGTTG

GTCCCTCAGGCTTCATCC

GAGCAGAAGTCACCGAATC

~GTATGTGAACGGCTCTG

~CTGTGATTGTCTGGATAGG

GTAGCCTTCTCACAGTCCTTTG

GGTACAGCACGCCAGCAC

~CCTAAGCAACAACTACAATC

~CACGGGAGTAGAAAGC

CGACCCTGCCTCTGAATCC

CTTTGTTTCTTTGTCCCTGTTGG

receptor (Egfr)
Retinoic acid receptor a
(Rara)
Secreted frizzled-related
sequence protein 1
(Sfrp1 )
Insulin-like growth factor I
receptor (Igf 1r)
Insulin-like growth factor 2
receptor (lgr2r)
Wingless-related MMTVintegration site 4 (Wnt4)
Lim homeobox protein 1
(Lhx1)
E-Cadherin
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Dickinson, San Jose, CA). Cells were seeded at 200 cells/mm2 in 6 well cell
culture dishes coated with 500

1-11

of Matrigel® (Becton Dickinson, San Jose, CA)

Fresh media was added every three days. Renal bodies were harvested after
two weeks for further analysis in situ.

Analysis of glomerular bodies was performed by seeding mK4 cells in 6
well cell culture dishes coated with 100

1-11

of Matrigel® in Dulbecco's modified

Eagle's medium supplemented with 10% fetal bovine serum lacking 5X mito
serum extender. After 4 days cultures were fixed in 50:50 Acetone methanol and
processed for immunocytochemistry using WT1 rabbit polyclonal (180) and
Thy1.1 mouse monoclonal antibodies visualized by goat anti rabbit 488 and goat
anti-mouse 568 AlexaFluor (Molecular Probes-Invitrogen, Carlsbad, CA).

WT1 expression vectors and selection

pSRV plasm ids containing all four WT1 splice variants from the 17aa/KTS
sites including WT1A(-I-), WT1 B(+/-), WT1 C(-I+), and WT1 D(+/+) were created
as described by Haber et al. (Haber et al., 1992). WT1 sequences were excised
with Bglli and inserted into p3XFLAG-CMV-14 expression vector (Sigma-Aldrich,
St. Louis, MO). mK4 cells were transfected with 1 I-Ig of each splice variant and
control vector. mK4 cells expressing vector derived gene products were selected
for with Geneticin® treatment (Inviitrogen, Carlsbad, CA). WT1 splice variant
overexpression was verified by QRT-PCR.
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Results

AHR and WT1 colocalize in developing and adult glomeruli
AHR protein is a ubiquitous protein expressed primarily in lung, thymus,
liver, gut mucosa, kidney, and urogenital tissue (Jain et al., 1998).
Immunohistochemical (lHe) analysis revealed ubiquitous expression of the AHR
throughout all parts of renal tissw:; with strongest signals occurring in glomeruli
and endothelial cells of major renal vascular structures (Figures 1 A, B, and e).
DuallHe analysis for AHR and \/\IT1 was employed to determine cellular
specificity and colocalization. In adult glomeruli, the strongest AHR signal
colocalized with WT1 staining in the podocyte population (Figures 2A and B). In
glomeruli of developing metanephros, AHR and WT1 colocalization occurs in the
majority of the cell populations (Figures 1e and D). This pattern is consistent
with the known role for WT1 in mesenchymal-to-epithelial cell transition and the
emerging role for AHR in renal dE!velopment (Falahatpisheh and Ramos, 2003;
Falahatpisheh and Ramos, 2007; Nanez and Ramos, 2007; Scharnhorst et aJ.,
2001 ).

siRNA-mediated Degradation of AHR Downregulates Renal Cell
Differentiation Markers
We have previously shown that exposure of metanephric organ cultures to
BaP, an environmental hydrocarbon that acts as an AHR ligand, inhibits
nephrogenesis in a manner dependent upon AHR protein expression
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Figure 1. AHR expression in adult mouse kidney. AHR expression is highest
in epithelial celis of renal vasculature and in glomerular podocytes.
Immunohistochemical analysis of AHR protein as visualized by 3, 3'diaminobenzidine (DAB) staining of formalin-fixed paraffin-embedded adult
mouse kidney sections. In Panel A, AHR signal (brown color) localizes to the
celis lining the renal vasculature. Panels Band C compare AHR and WT11
signal, respectively in adult glomeruli. Intense AHR signal (denoted by arrows)
shows patterns indicative of podocyte expression when compared to WT1 signal.
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Figure 1
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Figure 2. AHR colocalizes with WT1 expression. AHR and WT1 colocalize in
the developing and adult kidney. Dual immunohistochemical analyses of AHR
and WT1 proteins visualized using 3, 3', 5, 5'-tetramethylbenzidine (TMB) and
NovaRED, respectively. Panels A and C are representative images taken of
glomeruli from adult C5"7BLl6J mouse kidneys or E11 cultured metanephros
cross-sections. In panel B, maximal AHR signal (blue color denoted by arrow)
was measured using Zeiss Axiovision Rei 4.3 image analysis software. Positive
AHR signal is outlined in red. AHR-WT1 colocalization was defined by a positive
nuclear WT1 signal in proximity to the outlined AHR signal, as denoted by
arrows. Because of the diffuse nature of the AHR signal throughout metanephroi
in panel D, AHR-WT1 colocalization was determined by overlay of AHR and
WT1signals. Normalized signal was always <10% in sections stained separately
with individual antibodies. Panels E and F are serial cross sections of C57BLl6J
E11 cultured metanephroi analyzed for AHR alone or AHR-WT1 colocalization as
described. The scale in panels A-D was 25 I-lm, and in panels E and F 100 I-lm.
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(Falahatpisheh and Ramos, 2003; Falahatpisheh and Ramos, 2007; Nanez and
Ramos, 2007). In this model, BaP binds AHR resulting in nuclear translocation
thus promoting transcription of AHRE containing xenobiotic metabolizing
enzymes, and culminates in proteasomal degradation of AHR protein. To
determine the effects of AHR degradation irrespective of ligand activation, mK4
cells of metanephric cell lineage were exposed to pooled siRNA directed against
AHR. Seventy two hour siRNA exposure resulted in loss of AHR protein and
mRNA (Figures 3A, B, and C). Exposure to AHR siRNA and subsequent loss of
AHR protein resulted in downregulation of Igf1 r, Wnt4, Igf2r, and E-cad as
determined by quantitative RT-PCR (QRT-PCR) (Figure 3D). The mesenchymal
marker Sfrp1 and Lhx1 did not change (Figure 3D). To determine if constitutive
AHR degradation altered markers of renal cell differentiation, we examined mK4
cells expressing the pSilencer 4.1 CMV hygro vector containing a sequence that
when transcribed produces a 19-mer hairpin with a loop and 3' terminal overhang
that is processed by cellular machinery to produce siRNA (vsiRNA) (Paddison et

al.,2002). After selection with hygromycin, cell populations expressing AHR
vsiRNA exhibited reductions in AHR protein and mRNA (Figures 4A, B, and C).
Constitutive AHR degradation resulted in decreased expression of Sfrp1, Igf1 r,
Igf2r, Lhx1 and E- cad mRNA (Figure 4D). However, unlike conventional siRNA,
AHR vsiRNA resulted in an induction of \Nnt4 and reductions in Sfrp1 and Lhx1.
These differences may be due to separate functionally redundant transcriptional
pathways activated after prolonged AHR degradation.
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Figure 3. siRNA-mediated degradation of AHR downreglulates renal cell
differentiation markers. mK4 cells were cultured and seeded at 30 cells/mm2 in

the presence of 150 nM pooled siRNA targeted for AHR or a nonspecific
sequence for 3 days. Cells were processed for RNA isolation, cDNA synthesis,
and protein extraction. Quantitative PCR was performed with values
representing

~~CT-normalized

fold change relative to DMSO control (dashed

line). Variance represents standard deviation between at least three biological
replicates. Statistical significance was calculated using a Wilcoxon rank sum. In
panels A-C, siRNA directed towards AHR results in loss of I\HR protein and
mRNA. In panel 0, loss of AHR results in downregulation of Igf1 r, Wnt4, Igf2r,
and E-cad.
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E-cad

Figure 4. Vector-mediated siRNA degradation of AHR downregulates renal
cell differentiation markers. mK4 cells were seeded at 50 cells/mm2 and
transfected with vectors containing siRNA sequences targeted for WT1 or a
nonspecific. After two weeks selection with hygromycin, mK4 populations
containing stable siRNA expression were processed for RNA isolation, cDNA
synthesis, and protein extraction. Panel A and 8, Western blot analysis of AHR
protein normalized to a-tubulin loading control. siRNA directed towards AHR
results in loss of AHR protein. Panel C and D, Quantitative PCR was performed
with values representing LlLlCT-normalized fold change relative to DMSO control
(dashed line). Variance represents standard deviation between at least three
biological replicates. Statistical significance was calculated using a Wilcoxon
rank sum. vsiRNA reduces Sfrp1, Igf1 r, Igf2r, Lhx1, and E-cad.
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E-cad

siRNA-mediated Degradation Induces -KTS WT1 mRNA and Downregulates
Direct WT1 Transcriptional Targets
Our next set of experiments examined whether AHR degradation was
solely responsible for WT1 dysregulation. Using QRT-PCR, we measured
relative amounts of -KTS and +KTS WT1 mRNA, as well as, known WT1
transcriptional targets directly regulated by WT1 (Synd1 Pax2, Egfr, Rara, TauT)
(Han and Chesney, 2003; Ryan et al., 1995; Saxen, 1987; Vainio et aI., 1999).
Both siRNA and vsiRNA-mediated AHR degradation resulted in an induction in KTS and reduction in +KTS (Figures 5A, B, C, and D). In agreement with the
known role of -KTS WT1 as a transcriptional suppressor (Menke et al., 1998a),
AHR siRNA resulted in decreased expression of known targets Synd1, Pax2,
Egfr, Rara , and TauT (Figure 5E). Constitutive vsiRNA-mediated AHR
degradation resulted in selective downregulation of Synd1, Egfr, and TauT
(Figure 5F). In contrast to siRNA, AHR vsiRNA did not alter Pax2 and induced
Rara (Figure 5F). These results implicate a pathway whereby disruption of AHR
signaling via protein degradation shifts WT1 mRNA isoform ratios towards -KTS
resulting in functional changes in known WT1 transcriptional targets.

siRNA-mediated Degradation of WT1 Downregulates Direct Transcriptional
Targets and Renal Cell Differentiation Markers
To compare the molecular consequences of elevated -KTS mRNA to loss
of WT1 protein, mK4 cells exposed to WT1 siRNA were examined for mRNA
expression of renal cell differentiation markers and known WT1 targets. WT1

134

Figure 5. Loss of WT1 protein correlates with -KTS induction and target
gene downregulation. In panels A, 8, and E, mK4 cells were cultured and
seeded at 30 cells/mm2 in the presence of 150 nM pooled siRNA targeted for
WT1 or a nonspecific sequence for 3 days. Cells were processed for RNA
isolation and cDNA synthesis. Quantitative PCR was performed with values
representing ,1.,1.CT-normalized fold change relative to DMSO control. Variance
represents standard deviation between at least three biological replicates.
Statistical significance was calculated using a Wilcoxon rank sum. siRNA
directed towards AHR resulted in --KTS induction and +KTS reductions that
correlated to loss of WT1 target Synd1, Pax2, Egfr, Rara and TauT mRNA
expression. In panels C, 0, and F, mK4 cells were transfected with vsiRNA
directed towards AHR. vsiRNA selection resulted in cell populations with
induced expression of -KTS and decreased expression of +KTS. WT1 targets
Synd1, Egfr and TauT were downregulated while Pax2 remained unchanged and
Rara was induced.
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siRNA resulted in downregulation of WT1 protein and mRNA (Figures 6A and B).
Similar to results seen with AHR siRNA-mediated -KTS induction, loss of WT1
protein resulted in downregulation of renal cell differentiation markers Sfrp1,
Igf1 r, Igf2r, Wnt4, and E-cad (Figure 6C). Lhx1 remained unchanged (Figure
6C). WT1 siRNA reduced mRNA expression of the WT1 transcriptional targets
Synd1, Pax2, Egfr, and Rara (Figlure 60).

Overexpression of WT1 mRNA Isoforms Downregulates WT1 Ttarge!t Genes

To determine the effects of specific WT1 isoforms on WT1 target genes,
cONA sequences containing the four variants -17aa/-KTS (WT1A), -17aa/+KTS
(WT1 C), and +17aa/+KTS (WT1 D) were cloned into a p3XFLAG-CMV-14
expression vector. mK4 cells stably expressing the vector were selected with
G418 and assayed for molecular endpoints of WT1 and target gene expression.
Figures 7A-O shows confirmatory evidence that selected populations specifically
expressed WT1A, WT1 B, and Wf1 0 mRNA isoforms in amounts significantly
higher than empty vector. Compared to empty vector, expression of WT1 A, C
and 0 resulted in downregulation of Synd1, Pax2, Egfr, and Rara mRNA as
evidences by QRT-PCR (Figures 7E and F). Although splice variant-specific
expression of WT1 protein was not measured, the data indicate that the amounts
of WT1 proteins produced by CMV promoter-driven overexpression are sufficient
to downregulate WT1 targets, re~lardless of mRNA isoform.
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Figure 6. siRNA-mediated degradation of AHR down regulates renal cell
differentiation markers. mK4 ceilis were cultured and seeded at 30 cells/mm2 in
the presence of 150 nM pooled siHNA targeted for WT1 or a nonspecific
sequence for 3 days. Cells were processed for RNA isolation, cDNA synthesis,
and protein extraction. Quantitative PCR was performed with values
representing i1i1CT normalized fold change relative to DMSO control (dashed
line). Variance represents standard deviation between at least three biological
replicates. Statistical significance was calculated using a Wilcoxon rank sum. In
panels A and 8, siRNA directed towards AHR results in loss of AHR proteiin and
mRNA. In panel C, WT1 siRNA results in downregulation of the differentiation
markers Sfrp1, Igf1 r, Igf2r, Wnt4, and E-cad. In panel D, WT1 siRNA results in
downregulation of the WT1 targets Synd1, Pax2, Egfr, and Rara.
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Figure 7. Overexpression of WT1 mRNA isoforms downregulates Wlr1
targets. P3XFLAG-CMV-14

exprE~ssion

vectors containing all four WT1 splice

variants from the 17aa/KTS sites including WT1A(-/-), WT1 8(+/-), WT1 C(-/+),
and WT1 0(+/+) were transfected into mK4 cells. mK4 cells expressing vector
derived gene products were selected by antibiotic resistance and examined for
expression of WT1 splice variants by QRT-PCR, panels A, 8, C, and D. Panels
E and F, overexpression of WT1 constructs downregulates 'NT1 targets Synd1,
Pax2, Egfr, and Rara.
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Matrigel Induces Formation of Metanephric Structures in mK4 Cells
To develop an in vitro model better-suited to examine the effects of WT1
splice variants on nephrogenesis, mK4 cells were seeded on Matrigel, a matrix
known to induce differentiation and aggregation of various cell types into
structures reminiscent of in vivo tissue ( for review see (Schmeichel and Bissell,
2003)). Culture of mouse mammary epithelial cells in matrigel promotes the
formation of morphologically distinctive mammary alveoli which, in response to
lactogenic hormones, produce milk (Li et al., 1999; Lin and Bissell, 1993;
Sympson et al., 1994). The data shown in Figures SA-C show that after 4 days
in culture, mK4 cell cultures developed aggregates resembling metanephric
bodies that closely resembled developing kidneys resected from E15 embryos
(Figure SO). Removal of mito serum extender from the media resulted in a
typical cell culture monolayer with a ring of cellular growth that contained bodies
morphologically resembling glomeruli (Figure 9A). Immuncytochemistry for
markers specific for glomerular podocytes (WT1) and mesangial cells (Thy 1.1)
revealed positive staining in glomerular structures (Figure 9B, C, and 0).
Collectively these data indicate that upon stimulation by matrix-related factors,
nascent cell lines derived from metanephric cell cultures can provide a useful
model for studying the molecular genetics of nephrogenesis.
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Figure 8. mK4 cells cultured on Matrigel form metanephric aggregates.
mK4 cells were cultured in full media plus mito serum extender in 6 well cell
culture dishes coated with 500 IJI of Matrigel®. Panels A -C, metanephric renal
bodies developed after 4 days of culture and showed morphological similarities to
E15 metanephroi, panel D.
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Figure 9. mK4 cells cultured on Matrigel form glomerular specific
structures. mK4 cells were cultured in full media in 6 well cell culture dishes

coated with 100 IJI of Matrigel®. After 4 days, cultures were processed for
immunocytochemical identification of glomerular markers. WT1 rabbit polyclonal
(180) and Thy1.1 mouse monoclonal antibodies were visualized by goat antirabbit 488 and goat anti-mouse 568 AlexaFluor. Panel A, DAPI stained nuclei
form a monolayer ring of cells around the outer portion of the cell culture we" with
morphologically visible glomeruli. Panel B, C, and 0, WT1 signal (green) and
Thy1.1 (red) colocalize in suspected glomerular structures. Arrows denote
glomerular structures.
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Discussion

The emergin!g role for AHR in nephrogenesis is intriguing and emphasizes
the need to understand the complexity of AHR signaling beyond xenobiotic
metabolism (Falahatpisheh and Ramos, 2003; Fernandez··Salguero et a/., 1995;
Lahvis et a/., 2000; Lahvis et al., 2005; McMillan and Bradfield, 2007b; Schmidt
et a/., 1996).

Previous work in this laboratory has shown that exogenous ligands

of the AHR inhibit

m~phrogenesis

via a mechanism requiring conservation of

AHR signaling and preservation of WT1 mRNA splice variant ratios and
expression of renal cell differentiation markers (Falahatpisheh and Ramos, 2003;
Falahatpisheh and Ramos, 2007; Nanez and Ramos, 2007').

In the present study we show that disruption of AHR signaling is linked to
the protein degradation machinery of tanJet cells in the developing kidney and
results in disruption of genetic signaling implicit in nephrogenesis. AHR
ubiquitination and degradation occurs both in the cytoplasm (Song and Pollenz,
2002), or upon nuclear translocation (Roberts and Whitelaw, 1999), and
ARNT/DNA binding (Song and Pollenz, 2003). However, members of the
proteasomal compl18!x and the series of events leading to degradation have yet to
be fully characterized.

Recent work has shown that AHR functions as an E3

ligase and associates with proteasomal complexes consisting of DDB1, ARNT,
TBL3 and CUL4B in the degradation of steroid sex receptors (Ohtake et a/.,
2007). Thus, it is likely that AHR participates in an auto-regulatory loop that
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promotes proteasornal degradation. In fact, the ubiquitin E3 ligase Itch, a family
member of the Nedd4/Rsp5p HECT domain-containing family has been shown to
participate in auto-ubiquitination facilitating its own proteasomal degradation
(Mouchantaf et al., 2006).

siRNA-mediated reduction in AHR protein results in a decrease of renal
markers of differentiation in agreement with pharmacological models of AHR
degradation (Nanez and Ramos, 2007). This is the first known report indicating
that a reduction in AHR protein is sufficient to disrupt expression of molecular
markers necessary in nephrogenesis. \tVnt4 is implicated in early nephron
development and di1ferentiation (Stark: et al., 1994). Sfrp1, most likely through
Wnt interactions, plays an important role in the mesenchymal to epithelial cell
transition manifested during tubule formation and bud branching (Yoshino et al.,
2001 b). Lhx1-null mice do not progress past mesonephric development (Shawlot
and Behringer, 1995a). Inhibition of the Igf1 r impairs kidney growth, as
evidenced by a reduction in nephrons and altered ureteric bud branching
(Murphy and Barron., 1993; Wada et at., '1993). E-cad-null mice have decreased
nephron number due to a failure of prope!r fusion of the metanephric
mesenchyme to the ureteric bud (Mah et aI., 2000). Conservation of AHR
expression and constitutive signaling via expression of the nonresponsive AHRd
allele, which does not degrade upon ligand binding, or treatment with antagonist,
maintains expression of renal cell differentiation markers (Nanez and Ramos,
2007). These findin9s associate functional molecular consequences resulting
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from disruption of constitutive AHR functions with the regulation of renal cell
differentiation.

We have shown that siRNA-mediated degradation of AHR results in
induction of the -KTS WT1 mRNA splice variant. Depending upon cell type and
stimulus, AHR functions in a diverse array of transcriptional complexes including
the classical AHR-ARNT, NF-kappa B, AP-1, and glucocorticoid receptor which
provide possible mechanisms for regulation of WT1 splicing. Of these, the
glucocorticoid receptor has been shown to associate with PGC-1, a known
regulator of co-transcriptional splicing (Knutti et al., 2001). Another possibility
involves direct binding of AHR to the major groove of the WT1 promoter which
contains two consensus AHR responsive elements within a regulatory region
known to

rE~gulate

transcription-coupled splicing events (Cohen et aI., 1997).

Determining the exact nature of AHR-WT1 promoter interactions and possible
effects on splicing machinery directly (Bentley, 2002) or indirectly by altering
elongation efficiency (Eperon et al., 1988; Roberts et al., 1998) remains an
ongoing focus of the laboratory.

Our findings demonstrating inductlion in -KTS secondary to the loss of
AHR are consistent with in vivo studies in which mice overexpressing the -KTS
isoform have severely compromised renal development, evidenced by increased
stromal tissue, decrE~ases in tubular epithelium and glomerular tuft, and altered
podocyte structure (Hammes et al., 2001). This is in agreement with previous
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work from the laboratory showing that in utero BaP exposure results in offspring
with reduced glomerular number and glomerular filtration due to podocytopenia
While the exact molecular consequences resulting from alterations of the four
abundant and biolo~~ically relevant isoforms of WT1 remains to be fully defined, it
is well-established that the -KTS mRNA encodes a protein that participates in
transcriptional activity, and that the protein encoded by +KTS mRNA associates
with splicing factors (Davies et a/., 1998; Hastie, 2001). In both metanephros
and mK4 cell cultures, BaP-induced shifts in -KTS WT1 mRNA resulted in
downregulation of differentiation markers, a finding consistent with the
morphological deficits seen in -KTS transgenic mice and in our in utero exposure
study. On!Joing studies will focus on the molecular consequences resulting from
overexpression of each 17aa/KTS WT1 splice variant in the context of renal cell
differentiation gene regulation.

Downregulation of WT1 protein did not induce WT1 targets for negative
regulation. It is possible that -50% WT1 knockdown was not sufficient to ablate
WT1 negative regulatory activity. Since \NT1 siRNA is not isoform specific, we
assume that mRNA splice variant ratios were unchanged and that the negative
regulatory role for -KTS is mediated more by the relative abundance of mRNA
isoforms than by the total amount of protein expressed. Ongoing studies will use
vector mediated WT1 siRNA to achieve more efficient degradation of specific
variants.
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The development of an organ culture model system has been an
important tool for discovery the molecular mechanism of ontogenesis. However
incompatibility with assays necessary for further mechanistic discovery led us to
examine alternative approaches. Extensive work carried out to recreate
vasculature, kidney, lung, skin, and mammary tissue using 3D matrices has
shown the promise and utility of 3D cultures in molecular biology (Sakurai et aI,
1997; Schmeichel and Bissell, 2003; Schuger et al., 1990). Our model of
Matrigel induced metanephric body formation agrees with the known role of
extracellular matrices (ECM) from both the ureteric bud and the metanephric
mesenchyme in ureteric branching morphogenesis. ECM protein expression is
tightly regulated via growth factor signaling pathways which in turn are regulated
by master switch transcription factors. Laminins compose the majority of the
mature basement membrane,and have been shown to participate in branching
morphogenesis and tubulogenesis (Engel, 1993). Exposure to anti-laminin5
blocking antibody inhibits renal development of cultured metanephroi by
preventing association with Q3f31 and Q6f34-integrin receptors (Zent et aI., 2001).
In addition, cells stemming from the ureteric bud must digest ECM proteins to
facilitate invasion. Both matrix metalloproteases (MMPs) and serine proteases
are known to facilitate renal development. Membrane-type matrix 1 (MT-1-MMP)
and MMP-2 oligonucleotide antisense inhibits metanephric development
dependent on the TIMP-2 inhibitor activity (Kanwar et al., 1999; Ota et al., 1998).
Thus, it is likely that renal morphogenesis requires elements secreted in the ECM
to initiate biological events necessary for the initial and continued progression of
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nephrogenesis. The extent to which AHR participates in the regulation of cellmatrix interactions in the developing kidney remains to be established. Work by
others has shown that expression regulates members of the MMP and laminin
families (Hillegass et al., 2006) and we recently established a gene network
where

AHf~

interacts closely with osteopontin and other matrix-associated

proteins (Johnson et aI., 2004).

The present studies further define a novel role for AHR in the regulation of
murine nephrogenesis. AHR expression is a key regulator of WT1 mRNA splice
variant homeostasis. Loss of AHR results in dysregulation of WT1 manifest in
inductions of -KTS and downregulation of WT1 targets and markers of renal cell
differentiatilon. The matrix-dependent stimulation of mK4 cells into metanephric
tissue may provide a useful model for examination of the molecular events
responsiblH for nephrogenesis.
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CHAPTER 5
DISCUSSION

Although WT1 has been widely studied with respect to renal development
and oncogenesis, many questions remain unanswered. The majority of work to
date has focused on putative WT1 targets and correlations between splice
variant expression and clinical outcomes in vivo (for review see (Niaudet and
Gubler, 2006)). A major gap in our knowledge is the limited amount of
information available about the putative factors that regulate splicing. Our work
demonstrating that loss of AHR expression results in -KTS mRNA induction
suggests AHR as putative regulator of WT1 mRNA splicing. This is in agreement
with our in utero studies where BaP exposure results in offspring with reduced
glomerular number and glomerular filtration due to podocytopenia. While the
exact molecular consequences resulting from alterations of the four abundant
and biologically relevant isoforms of WT1 remains to be fully defined, it is wellestablished that the -KTS mRNA encodes a protein that paliicipates in
transcriptional activity, and that protein encoding +KTS mRNA associates with
splicing factors (Davies et al., 1998; Hastie, 2001). In both metanephros and
mK4 cell cultures, Bap··induced shifts in -KTS resulted in downregulation of
differentiation markers, a finding consistent with the morphological deficits seen
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in -KTS transgenic mice and in our in utero exposure study. Ongoing work will
utilize constructs of all four KTS/17aa WT1 mRNA splice variants expressed in
cells of varying differentiation status to begin defining the mechanism by which
WT1 regulates the genetic cascade necessary for renal development. Our data
implicate the participation of AHR signaling in WT1-mediated regulation of
nephrogenE~sis.

Of direct importance to our work is the emerging role of AHR in renal
development. Studies have shown roles for AHR in cell proliferation, adhesion
and migration, all processes necessary for embryogenesis (for reviews see
(8arouki et 08/., 2007; Ohtake et al., 2007)). The Ramos laboratory has shown
that AHR-/- mice exhibit delayed nephrogenesis resulting in compromised renal
development as evidenced by nephropenia and decreases in renal vasculature
(Figure 1) (Falahatpisheh and Ramos, 2003; McMillan and Bradfield, 2007b).
We have also shown that these changes can be reproduced by proteasomal
decradation of AHR protein upon ligand binding . While our work has chiefly
focused on \NT1 dysregulation at the posttranscriptionallevel as a key
mechanism by which AHR exerts regulatory influences, little is known about
other possible mechanisms that may contribute to deficits in nephrogenesis, such
as direct transcriptional regulation of renal cell differentiation markers or
participation in proteasomal degradation of renal regulatory proteins (Figure 2).

A major theme of this dissertation revolves around the developmental
deficits associated with disruption of WT1 signaling and differentiation resulting
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Figure 1. AHR-/- mice exhibit deficits in renal development with
consequE!nCeS in adult kidney morphology. Hematoxylin and Eosin stain of

developing mouse metanephros shows that AHR-/- have less developed
embryonic kidneys. Latex cast of AHR-/- adult kidneys have less vascularization
compared to wild type mice.
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Figure 2. Schematic detailing the complexity of possible mechanisms by
which Ahr may regulate WT1. Transcriptional activity may directly regulate
splicing factors. AHR may participate in proteolytic degradation of factors implicit
in WT1 splicing.
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from the loss of AHR protein. In our earlier work, exposure of wild type
metanephros to BaP leading to nephrogenic deficits similar to those seen in
untreated AHR-/- metanephros implicated AHR as a regulator of renal
development (Falahatpisheh et al., 2005). In agreement with known renal
deficits in AHR-/- mice, Chapters 1 and 2 used in vivo and in vitro models to
show that loss of AHR protein expression correlated with the downregulation of
renal cell differentiation markers, and WT1 dysregulation. This is the first report
showing that loss of AHR protein, regardless of biological context following ligand
binding, is sufficient to disrupt expression of molecular markers implicit in
nephrogenesis. To date, most studies implicating AHR in the development of
liver, cardiovascular, and reproductive organs have shown strong correlations for
AHR involvement, but lack any direct evidence of interactions with downstream
effectors responsible for disruption of organ development (Fernandez-Salguero
et al., 1995; Lahvis et al., 2000; Lahvis et al., 2005; Lund et aI., 2003; Lund et a/.,

2006; Schmidt et aI., 1996). Our discovery of AHR-dependent regulation of WT1,
a known renal master switch transcription factor, is the first study to propose a
direct mechanism for the role of AHR in ontogenesis (Figure 3).

A theme consistent in all of our studies is that loss of the AHR induced by
BaP, TCDD, siRNA AHR exposure, or genetic manipulation in AHR-/- mice
(Falahatpisheh and Ramos, 2007) results in the downregulation of known
markers of renal cell differentiation Sfrp1, Lhx1, Igf1 r, Igf2r, Wnt4, and E-cad
(Barnes et aI., 1994; Cho et aI., 1998; Dong Van Huyen et al., 2003; Stark et al.,
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Figure 3. Conceptual framework for AHR regulation of nephrogenesis.
Constitutive AHR signaling regulates WT1 function allowing for normal
nephrogenesis. Exogenous AHR ligands in the form of PAHs initiates a
response that results in WT1 dysregulation as evidenced by changes in the
amounts of mRNA splice variants that ultimately disrupt the cascade of genetic
events responsible for nephrogenesis
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Figure 3
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1994; Vainio et al., 11989; Yoshino et al., 2001b). While the involvement of WT1
in the regulation of targets such as Wnt4 (Sim et aJ., 2002) have been previously
made, the mechanisms by which loss of AHR protein downregulates target gene
expression remain unknown. 'Wnt4 is limplicated in early nephron development
and differentiation, and has been identified as a possible

re~~ulator

of AHR

transcription in prostate cancer cells (Chesire et aJ., 2004; Stark et aI., 1994).
This suggests a possible scenario in which loss of AHR results in WT1
dysregulation and subsequent downregulation of Wnt expression leading to
generalized disruption of protranscriptional signals derived from Wnt/beta-catenin
signaling and further loss of AHR protein. Sfrp1, through Wnt antagonistic
interactions, plays an important role in the mesenchymal-to-·epithelial cell
transition during tubule formation and bud branching. Sfrp1 contains AHRRE
elements in the regulatory region, suggesting the AHR may also regulate Wnt
signaling via Sfrp1 transcriptional control (Yoshino et al., 2001 b). In a similar
manner, the inhibition of the

1~lf1

r impairs kidney growth, as evidenced by a

reduction in nephrons and altered ureteric bud branching (Murphy and Barron,
1993; Wada et aJ., 11993). Activation of the Igf1 r necessitates binding of
extracellular insulin growth factors (IGF), a process that is tightly regulated by a
family of proteins named insulin growth factor binding protein (IGFBP). AHR is a
known regulator of IGFBP expression and may alter Igf1 r activity through
induction of IGFBP proteins (Johnson et aI, 2004; Marchand et al., 2005).
Perhaps the best marker of renal epithelial cell differentiation is E-cad as
transition from mesenchymal to epithelium results in increased expression of this
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critical epithelial gene (Cho et a/., 1998). E-cad-null mice have decreased
nephron number due to a failure of proper fusion of the metanephric
mesenchyme to the ureteric bud (Mah et al., 2000). Snail binds to the E-cad
promoter repressing mRNA and protein expression (Nieto, 2002). Depending on
cell type, snail expression can be repressed by modulators including fibroblast
growth factor (FGF) releasing inhibitory control of E-cad and inducing
mesenchymal-to-epiithelial cell transition (Nieto, 2002). Of relevance to our work
are studies identifying AHR as a transcriptional inducer of snail/slug family
members (Ikuta and Kawajiri, :2006). In addition to direct regulation via WT1
(Hosono et al., 2000), it is possible that AHR signaling may regulate E-cad
expression through snail/slug dependent pathways. While these markers have
yet to be fully examined in AHR-null mice, the preservation of AHR expression
and constitutive signaling via expression of AHRd or treatment with antagonist,
restores their expression. In conclusion, the diverse mechanistic possibilities for
AHR regulation of renal cell differentiation markers further highlights the
importance of conservation of AHR

signalin~1

in renal cell differentiation and

development.

The work presented in this study identified several novel roles for the
AHR, in addition to its well-established functions as a regulator of XME.
Evidence compiled from studies using AHR-/- mice, hydrocarbon exposure, and
nonmammalian AHR homologlues has implicated AHR as an early regulator of
mammalian development (Falahatpisheh and Ramos, 2003; Falahatpisheh and
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Ramos, 2007; McMillan and Bradfield, 2007b; Nanez and Ramos, 2007; Puga et
al., 2005). ExpressiDn of AHR is conserved across vertebrate and invertebrate

species (Hahn, 2002; Hahn et aI., 2006) with developmental functions ranging
from limb growth to neuronal development (fDr review (Barouki et al., 2007)). The
AHR homologue in Drosophila melanogaster Spineless (ss) regulates leg
structures through both transformation and deletion mechanisms and regulates
bristle size (Duncan et al., 19918). Loss of AHR 1 in the Calenorhabditis elegans
ortholog of AHR, results in cell axonal migration deficits resulting in impaired
neuronal differentiation and function (Duncan et al., 1998; Gin et al., 2006).
AHR-/- mice exhibit deficits in vascular structures stemming from a failure of the
ductus venosus to close and result in reduoed liver weight, microvesicular fatty
metamorphosis, prolonged extramedullary hernatopoeisis, and portal
hypercellularity (Fernandez-Salguero et al. ,1995; Lahvis et al., 2000; Lahvis et
al., 2005; Schmidt et aI., 1996). Of direct relevance to renal function are

experiments in which AHR -/- mice were found to have cardiac hypertrophy and
elevated mean arterial pressure (Lund et aI., 2003; Lund

E:~t

aI., 2006).

Hypertension correlated to inductions in endothelin-1 and angiotensin II, known
regulators of cardiomyocyte hypertrophy (Gavras and Gavras, 2002; Yamazaki et
al., 1996).

In studies of fetal TeDD exposure, a PAH that exerts its biological effects
solely through AHR disruption, wild type mice exhibited cleft palate,
hydronephrosis, small kidneys, and tortuous ureters (Peters et al., 1999b).
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TeOO-induced fetal deficits were shown to be regulated by transcriptional
activation as mice expressing AHR with a mutated bHLH re9ion (AHRbHLH-/-)
were protected (Peters et a/., '1999b). This study failed to characterize AHR
expression which is likely regulating TeDO-induced developmental deficits.
Thus, it is likely that in wild type mice TeOO activates AHH resulting in
proteasomal degradation, disruption of AHR si!Jnaling and

fE~tal

programming.

However in AHRbHLH-/- mice, TeOO exposure does not result in transcriptional
activation, a key step in ligand mediated AHR degradation. thus conservinfJ AHR
protein expression and constitutive signaling. These results support our own
studies in which siRNA-mediated AHR degradation alters expression of
differentiation markers and deregulates WT1 activity as WE:!! I as data from AHR-/mice (Falahatpisheh et a/., 2007). Further evaluations using alternative mouse
models of varying AHR genotype such as 02N mice with nonresponsive lifland
binding AHR d , or AHR-/- null mice lacking AHR protein, will lend further insight to
this hypothesis.

The work presented in this study is the first report of a role for AHR in
alternative splicing. Our model detailing a constitutive function for AHR in VVT1
regulation is supported by the finding that prevention of AHH loss
pharmacologically, or by the use of the genetically-resistant 02N strain,
prevented renal developmental deficits in SaP-treated metanephros, and
restored normal ratios of WT1 mRNA isoforms. The complexity of AHR functions
in different transcriptional complexes such as the classicall J\HH-ARNT, NF-
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kappa B, AP-1, and glucocorticoid receptor provides possible mechanisms for
regulation of WT1 splicing (Figure 4). As mentioned in Chapter 3, the
glucocorticoid receptor associates with PGC-1, a known

rE~'gulator

of co-

transcriptional splicing (Knutti et al., 2001). An ongoing focus of the laboratory is
the possibility of direct binding of AHR to the WT1 promoter. The WT1 promoter
contains two consensus AHR responsive elements within a

re~lulatory

region

known to regulate transcription-coupled splicing events (Cohen et aI., 199/').
Wild type mK4 cells and clones expressing stable constructs for siAHR are being
analyzed by chromatin immunoprecipitation for AHR-WT1 promoter associations.
AHR may function to alter the splicing machinery directly (Bentley, 2002), or
indirectly by altering elongation efficiency (Eperon et al., 19B8; Roberts et aI.,
1998). Ohtake et aI., presented a novel role for AHR as an E3 ligase in the
proteasomal degradation of estrogen (ER) and androgen receptors (AR) through
associations with proteasomal complexes consisting of DDB 1, ARNT, TBL3 and
CUL4B, and has E3 ligase activity. We postulate that AHF~ may indirectly
participate in proteasomal degradation of splicing factors. In fact, ER has been
shown to associate with spliceosome complexes in the nucleus (Kato et aI.,
2005). This creates a scenario in which AHR through E3 ligase control of ER
activity inherently regulates assembly and/or processivity of splicing complexes
necessary for regulation of genes such as WT1 (Figure 5).

Little is known as to the exact molecular consequences resulting from
alterations of the four abundant and biologically relevant isoforms of WT1. It is
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Figure 4. Schematic detailing the complexity of AHR transcriptional
interactions. Depending upon cell type and stimulus AHR can interact with
different transcriptional complexes such as the classical AHR-Arnt. NF-k8lppa B,
AP-1, and glucocorticoid receptor.
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Figure 5. AHR may act as an E3 ligase in the proteasomal degradation of
estrogen and androgen receptor. AHR associates with proteasomal

complexes consisting of DDB1, Arnt, TBL3 and CUL4B.

170

Figure 5

r----

Cyp1A1
Cyp1A2
Cyp1B1
GSTYa
NAD(P)Hquinone

oxidoreductase

1
-----

Substrate
Proteolysis

171

well-established that the -KTS mRNA encodes a protein that participates in
transcriptional activity, and that protein encoding +KTS

ml~NA

associates with

splicing factors (Davies et al., 1998; Hastie. 2(01). Mice overexpressing the KTS isoform have severely compromised renal development, evidenced by
increased stromal tissue, decreases in tubular epithelium and glomerular tuft,
and altered podocyte structure (Hammes et aI., 2001).

In both metanephros and

mK4 cell cultures, BaP-induced shifts in -KTS resulted in downregulation of
differentiation markers, a finding consistent with the morpbological deficits seen
in -KTS transgenic mice.

However, a potential role of AHR in the regulation of

WT1 splicing is of importance as human clinical conditions such as Denys--Drash
syndrome, WAGR, and Frasier syndrome are associated with deregulation of
normal splice variant ratios (Niaudet and Gubler, 2006). R:estoring WT1 mRNA
splice variant ratios via AHRd expression di(j not alter renal differentiation
markers. Transgenic mice expressing solely +17aa WT1 do not exhibit gross
renal nephropathy (Natoli et aI., 2002), but have deficits in other organ systems
such as the olfactory system (Wagner et al., 2(05).

The coordination of cell proliferation, apoptosis, adhesion, migration,
differentiation, and vasculogenesis is necessary for successful ontogenesis
(Larsen et aI., 2001). Our data suggests a plausible role for AHR regulation of
extracellular matrices (ECM) involving cellular interactions between the ureteric
bud and the metanephric mesenchyme in branching morphogenesis. ECM
protein expression is tightly regulated via growth factor signaling pathways which

172

in turn are regulated by master switch transcription factors. Cells stemming from
the ureteric bud must digest ECM proteins to facilitate invasion. Both matrix
metalloproteases (MMPs) and serine proteases are known to facilitate
degradation of ECM proteins necessary in renal development. Membrane-type
matrix 1 (MT-1-MMP), MMP-2, and MMP-9 have been characterized as
regulators of ECM interaction in the developing kidney (Kanwar et aI., 1999; Ota
et aI., 1998). Rat models examining the effects of maternal diabetes implicate

TGF-beta as a possible MMP (Duong Van Huyen et al., 2007). In fact, cDNA
array studies have revealed that many genes involved in ECM regulation and
maintenance are targets for the AHR (Andreasen et al., 2006; Hillegass et al.,
2006). In metanephric culture, inhibition of Smad4, a key mediator of TGF-beta,
in the nephrogenic mesenchyme impairs mesenchymal induction (Oxburgh et al.,
2004). Using mouse fibroblasts of varying AHR genotype, loss of AHR
expression correlated to increased TGF-beta production and excretion
suggesting a possible ligand-independent role in TGF-beta regulation (Chang et

al.,2007). Taken together, these results implicate AHR signaling in the
regulation of ECM regulatory proteins and pose an alternative mechanism for its
role in renal development.

Our model of Matrigel-induced metanephric body formation agrees with
the known role of (ECM) from both the ureteric bud and the metanephric
mesenchyme in ureteric branching morpho£lenesis. Matrigel is composed of a
mixture of mouse tumor derived extracellular matrix proteins including laminin,
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collagen IV, heparin sulfate proteoglycan and enactin (manufacturer's product
insert). While the exact makeup of Matrigel remains unknown for proprietary
reasons, studies have characterized laminin as the most abundant and reactive
ingredient (Schmeichel and Bissell, 2003). This is of direct interest to our work in
that lam in ins are key structural proteins in the renal basement membranes
(Engel, 1993), and known to participate in branching morphogenesis and
tubulogenesis. Laminin 1, consisting of a-,

~-,

and v-subunits, is a critical

component of epithelial cell polarization chiefly expressed in comma and Sshaped bodies (Ourbeej et al., 1996; Ekblom, 1993). Of importance to future
studies, is that exposure to anti-laminin5 blocking antibody inhibits renal
development of cultured metanephroi by preventing association with
a6~4-integrin

a3~1

and

receptors (Zent et al., 2001). Recent studies have implicated

integrin signaling as effectors for ECM-mediated signaling (Sonnenberg et al.,
1990). In fact exposure to antibodies generated against a1, or a1 ~1Y1-subunits
inhibits development of cultured metanephroi either through binding of the
dystroglycan membrane complex or the

a6~1-integrin

receptor (Sonnenberg et

al., 1990). Ongoing work is focusing on the identification of the exact

components necessary for stimulation of metanephric bodies from embryonic
renal cell lines and the extent of integrin signaling.

Typically, markers of renal nephropathy such as urinary
albumin/microprotein, blood urea nitrogen, and creatinine measures generally
manifest in already severely compromised clinical conditions (Halperin and
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Kamel, 2000). Similarly, studies examining the embryotoxicity and teratogenicity
of PAH compounds focused on overt developmental differences (Lummus and
Henningsen, 1995; MacKenzie and Angevine, 1981 a; Peters et al., 1999a;
Rodriquez et al., 1999; Wells et al., 1997; Winn and Wells, '1997) Our findings of
modest changes in glomerular number, urinary albumin, and podocyte number in
response to PAH exposure highlight the need to reevaluate endpoints for
developmental deficits and measure subtle effects which are a better estimate of
human environmental exposure and risk of renal disease. Novel renal
biomarkers such as RPA 1, GSTYb1, and GSTMu are designed to detect
nephropathy with more sensitivity than conventional methods (Falkenberg et al.,
1996; Hildebrand et al., 1999; Kilty et aI., 1998). Our laboratory has developed
expertise in the characterization of modest, significant changes in glomerular cell
populations that accompanied with traditional pathology can provide a more
effective, quantitative evaluation of glomerular injury (Nanez et aI., 2005; Nanez
and Ramos, 2007).

ThH bioavailability of PAHs from exposures due to incompletH burning of
organic substances such as gas, oil, wood, tobacco, and charbroiled meat
present a ready source for potential regulators of development. Average PAH
exposure can range from 3 to 15

~g/day

depending on dietary intake and are

doubled with exposure to active or passive tobacco smoke (Menzie et al., 1992a;
Menzie et al., 1992b; Rebagliato et aI., 1995; Santodonato et al., 1981).
Classical studies establishing PAHs as known embryotoxic and teratogenic
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agents used dosages of BaP ranging from 10 mg/kg to 250 mg/kg, thus far
exceedin~1

even that of the highest possible human exposure (Lummus and

Henningsen, 1995; MacKenzie and Angevine, 1981 a; Rodriquez et al., 1999;
Wells et a/., 1997; Winn and Wells, 1997).

To ascertain whether our in vitro model of AHR dependent BaP-induced
deficits in nephrogenesis correlated to effects obtained from environmentally
relevant PAH exposure we chose concentrations considerably lower than those
established for in utero toxicity and teratogenicity (Lummus and Henningsen,
1995; MacKenzie and Angevine, 1981 a; Rodriquez et al., 1999; Wells et aI.,
1997; Winn and Wells, 1997). When normalized for species-dependent temporal
difference~s

in development, this exposure is representative of human exposures

of at risk populations (Menzie et aI., 1992a: Menzie et aI., 1992b; Rebagliato et
aI., 1995). While the classical studies were of great mechanistic importance,
recent efforts have highlighted the importance of using exposure regimens better
approximating human models of environmental disease (for reviews see (BeruBe
et al., 2007; Ng et al., 2006a; Pope, 2007)). Our findings detailing renal deficits

resulting from in utero BaP exposure are unique in that they chronicle
nephropathy from early post-birth through adulthood. The use of the D2N mouse
model allowed us to determine that ligand binding in utero mediates PAH
induced developmental renal deficits. Our in utero studies not only implicate
PAH exposure in fetal programming of adult renal diseases and ensuing
complications, but provide evidence for a direct mechanism, Ongoing work will
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use genetic mouse models with mutations affecting AHR and WT1 biology to
further deilineate the mechanisms of PAH-induced renal deficits.

Our model, in which maternal BaP insul,t results in decreases in podocyte
number that impair glomerular filtration, is strikingly similar to clinical
manifestations seen in conditions such as focal segmental glomerulosclerosis
(FSGS) or diabetic nephropathy (Hara et a/." 2001; Hayden et aI., 2005; Kim et
a/., 2001 ; Wolf et aI., 2005). Podocytes are terminally differentiated cells that line

the glomerular basement membrane (GBM) acting as a filter mediated sizeselectivity and must structurally encompass the entire glomerular surface with
foot processes to maintain proper filtration (Wiggins, 2007). Podocytopenia
caused by a number of mechanism including toxic, genetic, immune, infectious
and hemodynamic results in denudation of the GBM that compromise glomerular
function initiating a cycle of injury and continued podocyte loss leading to
progressive renal failure (Wiggins, 2007). Glomerulopathies are the most
common causes of end-stage renal disease worldwide (Hricik et a/., 1998). Of
interest, are findings from in vivo studies in rats where weekly 10 mg/kg BaP
exposure of female Sprague-Dawley rats resulted in progressive elevations in
total urinary protein, protein/creatinine ratios and microalbuminuria (Nanez et a/.,
2005). The nephropathic response involved early reductions in mesangial cell
numbers coupled to podocyte injury as evidenced by effacement of foot
processes. Of note was that podocytes, the only renal cell type expressing WT1
and high AHR protein amounts, in comparison to their glomerular cell types, were
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affected by BaP exposure. This suggests a scenario, currently being tested, in
which PAH-induced fetal programming of renal disease may be exacerbated by
repeated PAH exposures throughout adulthood. Support of this view derives
from studies showing that BaP exacerbates nephropathy in diabetic rats
(Valentovic et al., 2006). The impact of in utero BaP exposure on other
glomerular cell populations such as

mesan~Jial

and endothelial cells remains to

be determined. However, we have obtained evidence that BaP compromises
mesangial and podocyte cell dilfferentiation in adult rats (Nanez et aI., 2005).

Of relevance to our work is the extensive evidence linking maternal PAH
exposure to fetal deficits. Some of the strongest evidence of fetal programming
involves the correlation

betweE~n

low birth weight (LBW) and compromised renal

development and initiation of the cycle involving HTN, glomerulosclerosis,
nephron loss, and progressive renal failure (Celsi et al., 1998; Nwagwu et al.,
2000; Sanders et aI., 2005; Zandi-Nejad et al., 2006). Fetal tobacco syndrome
characterized by maternal exposure to PAHs in the form of tobacco smoke
results in reductions in birth weight, height, thoracic circumference (for review
see (Nieburg et al., 1985). The hypothesis that active smoking morphologically
alters the placenta compromising fetal capillary function resulting in a reduction
of oxygen flow to the developing fetus is supported by data in both human and
rodent models (Bush et al., 2000a; Bush et al., 2000b). Sasaki et al. has
provided the first in vivo human evidence that AHR, CYP1A1, and GST1 genetic
polymorph isms influence fetallhealth upon maternal tobacco smoke exposure.
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Expression of AHR protein with arg/arg at codon 211 significantly lowered birth
weight and length. Interestingly, variants of enzymes regulated by AHR activity
(CYP1A1 m1/m2 + m2/m2) or linvolved in PAH elimination (GSTM1 -1-) sensitized
fetuses to the effects of maternal smoking (Sasaki et al., 2006). This study
directly links PAH exposure to deficits in AHR signaling in the context of fetal
programming.

The increasing bioavailability of exogenous disruptors of AHR signaling
and the identification of novel endogenous AHR regulators highlights the need for
a broader understanding of mechanisms by which AHR participates in renal
development and cellular differentiation. Our results identify AHR-dependent
glomerular deficiencies as the causative factor of in utero BaP-induced
deficiencies in renal development. At the mechanistic level, these deficits are
elicited via disruption of constitutive AHR signaling results in downregulation of
renal cell differentiation markers, dysregulation of WT1 mRNA splice variants,
and decreases in direct WT1 transcriptional targets (Figure 6).

In summary, the work presented in this dissertation defines a novel role for
the AHR in renal development and in fetal programming of PAH-induced
environmental disease. Ongoing studies will require further definition of
molecular interactions between AHR and WT1 and the novel specific roles of
AHR in the regulation of nephrogenesis. The nature and extent of AHRregulated interactions in mediating renal developmental control that set the stage
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Figure 6. Schematic detailing renal cell differentiation.. Renal cells of
mesenchymal phenotype undergo a series of temporally precise genetic events
that activate or repress the expression of numerous genetic elements. WT1 is a
master switch that regulates the key transition from mesenchymal cells to
epithelial cells. The aryl hydrocarbon receptor (AHR) is an important nuclear
transcription factor both during embryogenesis and throughout maturity in
multiple organisms. Evidence is presented that AHR regulates WT1 splice
variant expression altering renal cell differentiation.
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for adult renal disease following exposure to environmental ligands of the
receptor is an important hypothesis that warrants further investigation.
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